| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 SLC25A20 ATP7A ATP7B SLC19A3 SLC44A2 SLC6A15 SLC12A8 SLC46A1 BCL2A1 SPNS3 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 ABCA9 SLC22A17 SLC16A12 RHAG CALHM2 SLC5A1 SLC12A5 SLC7A8 SLC41A2 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 P2RX6 CLDN17 SLC22A4 KCNJ12 SCN4A SLC35A2 SCN5A SCN9A SLC10A6 TMC8 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G MFSD8 SLC5A8 KCNJ18 ATP1A1 ATP1A3 TMEM109 SLC12A7 SLC16A7 ATP2B4 SLC39A7 SLC35B1 | 6.49e-39 | 1180 | 150 | 64 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 SLC25A20 ATP7A ATP7B SLC19A3 SLC44A2 SLC6A15 SLC12A8 SLC46A1 BCL2A1 SPNS3 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 ABCA9 SLC22A17 SLC16A12 RHAG CALHM2 SLC5A1 SLC12A5 SLC7A8 SLC41A2 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 P2RX6 CLDN17 SLC22A4 KCNJ12 SCN4A SLC35A2 SCN5A SCN9A SLC10A6 TMC8 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G MFSD8 SLC5A8 KCNJ18 ATP1A1 ATP1A3 TMEM109 SLC12A7 SLC16A7 ATP2B4 SLC39A7 SLC35B1 | 1.32e-36 | 1289 | 150 | 64 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 ATP7A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC4A3 CALHM2 SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 P2RX6 CLDN17 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 TMC8 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G MFSD8 SLC5A8 KCNJ18 ATP1A1 ATP1A3 TMEM109 SLC12A7 ATP2B4 SLC39A7 | 1.47e-30 | 793 | 150 | 48 | GO:0015075 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 CALHM2 SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 P2RX6 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G SLC5A8 KCNJ18 ATP1A1 ATP1A3 TMEM109 SLC12A7 ATP2B4 SLC39A7 | 2.00e-28 | 664 | 150 | 43 | GO:0008324 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 ATP7A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC4A3 RHAG SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 CLDN17 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G MFSD8 SLC5A8 KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 | 3.39e-28 | 758 | 150 | 45 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A ATP7B SLC6A15 SLC12A8 SLC13A2 SLC1A3 SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G SLC5A8 KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 | 1.55e-27 | 465 | 150 | 37 | GO:0046873 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 RHAG SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G SLC5A8 KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 | 3.19e-27 | 627 | 150 | 41 | GO:0022890 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | ATP7A ATP7B SLC44A2 SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 ABCA9 SLC16A12 SLC5A1 SLC12A5 SLC7A8 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 SLC22A4 SLC35A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 ATP1A1 ATP1A3 SLC12A7 SLC16A7 ATP2B4 SLC35B1 | 5.51e-26 | 477 | 150 | 36 | GO:0022804 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC44A2 SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 SLC16A12 SLC5A1 SLC12A5 SLC7A8 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 SLC22A4 SLC35A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 SLC12A7 SLC16A7 SLC35B1 | 2.03e-25 | 296 | 150 | 30 | GO:0015291 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | ATP7A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 SLC10A6 SLC39A6 SLC13A5 SLC5A8 ATP1A1 ATP1A3 SLC12A7 ATP2B4 | 2.57e-20 | 301 | 150 | 26 | GO:0022853 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC6A15 SLC13A2 SLC1A3 SLC5A1 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SCN4A SCN5A SCN9A SLC10A6 SLC13A5 CACNA1I CACNA1H CACNA1G SLC5A8 ATP1A1 ATP1A3 | 9.59e-20 | 171 | 150 | 21 | GO:0015081 |
| GeneOntologyMolecularFunction | symporter activity | SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC5A1 SLC12A5 SLC6A12 SLC10A2 SLC12A3 SLC15A1 SLC22A4 SLC10A6 SLC39A6 SLC13A5 SLC5A8 SLC12A7 SLC16A7 | 3.26e-18 | 150 | 150 | 19 | GO:0015293 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC5A1 SLC12A5 SLC6A12 SLC10A2 SLC12A3 SLC15A1 SLC10A6 SLC39A6 SLC13A5 SLC5A8 SLC12A7 | 2.59e-17 | 119 | 150 | 17 | GO:0015294 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 BCL2A1 RHAG CALHM2 SLC12A5 P2RX6 CLDN17 KCNJ12 SCN4A SCN5A SCN9A TMC8 ORAI3 CACNA1I CACNA1H CACNA1G MFSD8 SLC5A8 KCNJ18 TMEM109 SLC12A7 | 1.72e-13 | 526 | 150 | 25 | GO:0022803 |
| GeneOntologyMolecularFunction | channel activity | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 BCL2A1 RHAG CALHM2 SLC12A5 P2RX6 CLDN17 KCNJ12 SCN4A SCN5A SCN9A TMC8 ORAI3 CACNA1I CACNA1H CACNA1G MFSD8 KCNJ18 TMEM109 SLC12A7 | 1.27e-12 | 525 | 150 | 24 | GO:0015267 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.85e-12 | 14 | 150 | 7 | GO:0008331 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC19A3 SLC6A15 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC4A3 SLC16A12 SLC7A8 SLC6A12 SLC35A3 SLC10A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 SLC16A7 SLC35B1 | 8.27e-12 | 293 | 150 | 18 | GO:0008514 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | SLC6A15 SLC13A2 SLC1A3 SLC6A12 SLC10A2 SLC10A6 SLC13A5 SLC5A8 | 1.67e-10 | 35 | 150 | 8 | GO:0005343 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 CALHM2 P2RX6 CLDN17 KCNJ12 SCN4A SCN5A SCN9A TMC8 ORAI3 CACNA1I CACNA1H CACNA1G MFSD8 KCNJ18 TMEM109 | 2.61e-10 | 459 | 150 | 20 | GO:0005216 |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | SLC6A15 SLC13A2 SLC1A3 SLC5A1 SLC6A12 SLC10A2 SLC12A3 SLC10A6 SLC13A5 SLC5A8 | 5.04e-10 | 81 | 150 | 10 | GO:0015370 |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | SLC19A3 SLC6A15 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC16A12 SLC7A8 SLC6A12 SLC10A2 SLC10A6 SLC13A5 SLC5A8 SLC16A7 | 5.53e-10 | 207 | 150 | 14 | GO:0046943 |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | SLC19A3 SLC6A15 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC16A12 SLC7A8 SLC6A12 SLC10A2 SLC10A6 SLC13A5 SLC5A8 SLC16A7 | 5.90e-10 | 208 | 150 | 14 | GO:0005342 |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A CACNA1D CACNA1E CACNA1F CALHM2 P2RX6 KCNJ12 SCN4A SCN5A SCN9A ORAI3 CACNA1I CACNA1H CACNA1G KCNJ18 TMEM109 | 6.93e-09 | 343 | 150 | 16 | GO:0005261 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | CMKLR2 OR5B3 OR5T3 HTR2A GPR25 OR4N5 OR4D10 CCR9 FPR1 FPR2 OR4D1 CHRM3 GPR179 EDNRB TAS2R9 TAS2R5 GPR61 SORCS2 MRGPRX4 OR4C12 TAS2R41 C5AR1 OR4A4P HCRTR2 GPRC5B | 1.02e-08 | 884 | 150 | 25 | GO:0004930 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | CACNA1A CACNA1D CACNA1E CACNA1F SLC8A1 SLC8A3 ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 1.94e-08 | 151 | 150 | 11 | GO:0015085 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.31e-08 | 26 | 150 | 6 | GO:0005248 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 4.91e-08 | 46 | 150 | 7 | GO:0005245 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | CMKLR2 OR5B3 OR5T3 FLT4 HTR2A GPR25 OR4N5 OR4D10 CCR9 FPR1 FPR2 OR4D1 CHRM3 SLC22A17 GPR179 EDNRB TAS2R9 TAS2R5 GPR61 NRXN2 P2RX6 AGER SORCS2 MRGPRX4 OR4C12 TAS2R41 C5AR1 OR4A4P HCRTR2 GPRC5B | 7.16e-08 | 1353 | 150 | 30 | GO:0004888 |
| GeneOntologyMolecularFunction | antiporter activity | SLC44A2 SLC7A6 SLC4A3 SLC7A8 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC35A2 SLC35B1 | 9.21e-08 | 138 | 150 | 10 | GO:0015297 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | CACNA1A CACNA1D CACNA1E CACNA1F KCNJ12 CACNA1I CACNA1H CACNA1G KCNJ18 TMEM109 | 2.28e-07 | 152 | 150 | 10 | GO:0022843 |
| GeneOntologyMolecularFunction | secondary active monocarboxylate transmembrane transporter activity | 2.39e-07 | 19 | 150 | 5 | GO:0015355 | |
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 3.74e-07 | 9 | 150 | 4 | GO:0015379 | |
| GeneOntologyMolecularFunction | UDP-galactose transmembrane transporter activity | 4.16e-07 | 3 | 150 | 3 | GO:0005459 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 4.16e-07 | 3 | 150 | 3 | GO:0008332 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | ANO9 SLC12A8 SLC4A3 SLC12A5 SLC6A12 SLC12A3 CLDN17 MFSD8 SLC12A7 | 4.36e-07 | 125 | 150 | 9 | GO:0015108 |
| GeneOntologyMolecularFunction | ankyrin binding | 6.75e-07 | 23 | 150 | 5 | GO:0030506 | |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 6.75e-07 | 23 | 150 | 5 | GO:0015377 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | CACNA1A CACNA1D CACNA1E CACNA1F KCNJ12 CACNA1I CACNA1H CACNA1G KCNJ18 TMEM109 | 1.20e-06 | 182 | 150 | 10 | GO:0005244 |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 1.30e-06 | 26 | 150 | 5 | GO:0015296 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | CACNA1A CACNA1D CACNA1E CACNA1F KCNJ12 CACNA1I CACNA1H CACNA1G KCNJ18 TMEM109 | 1.33e-06 | 184 | 150 | 10 | GO:0022832 |
| GeneOntologyMolecularFunction | gated channel activity | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 P2RX6 KCNJ12 TMC8 CACNA1I CACNA1H CACNA1G KCNJ18 TMEM109 | 1.49e-06 | 334 | 150 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | ANO9 SLC12A8 SLC4A3 SLC12A5 SLC6A12 SLC12A3 CLDN17 MFSD8 SLC12A7 | 2.13e-06 | 151 | 150 | 9 | GO:0008509 |
| GeneOntologyMolecularFunction | sodium channel activity | 2.49e-06 | 52 | 150 | 6 | GO:0005272 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 3.02e-06 | 83 | 150 | 7 | GO:0015101 | |
| GeneOntologyMolecularFunction | monocarboxylate:sodium symporter activity | 3.92e-06 | 15 | 150 | 4 | GO:0140161 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | SLC12A8 SLC12A5 SLC9A1 SLC12A3 KCNJ12 KCNJ18 ATP1A1 ATP1A3 SLC12A7 | 4.89e-06 | 167 | 150 | 9 | GO:0015079 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | ANO9 SLC12A8 SLC4A3 SLC12A5 SLC6A12 SLC12A3 CLDN17 MFSD8 SLC12A7 | 5.92e-06 | 171 | 150 | 9 | GO:0015103 |
| GeneOntologyMolecularFunction | calcium channel activity | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 5.95e-06 | 129 | 150 | 8 | GO:0005262 |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 6.99e-06 | 36 | 150 | 5 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 6.99e-06 | 36 | 150 | 5 | GO:0015662 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.43e-05 | 70 | 150 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 3.38e-05 | 9 | 150 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | amine transmembrane transporter activity | 3.38e-05 | 9 | 150 | 3 | GO:0005275 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 3.38e-05 | 9 | 150 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved SA node cell action potential | 5.61e-05 | 2 | 150 | 2 | GO:0086059 | |
| GeneOntologyMolecularFunction | P-type divalent copper transporter activity | 5.61e-05 | 2 | 150 | 2 | GO:0043682 | |
| GeneOntologyMolecularFunction | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | 5.61e-05 | 2 | 150 | 2 | GO:0099580 | |
| GeneOntologyMolecularFunction | P-type monovalent copper transporter activity | 5.61e-05 | 2 | 150 | 2 | GO:0140581 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 6.02e-05 | 90 | 150 | 6 | GO:0008028 | |
| GeneOntologyMolecularFunction | pyrimidine nucleotide-sugar transmembrane transporter activity | 6.56e-05 | 11 | 150 | 3 | GO:0015165 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 8.08e-05 | 59 | 150 | 5 | GO:1901505 | |
| GeneOntologyMolecularFunction | ammonium channel activity | 8.70e-05 | 12 | 150 | 3 | GO:0008519 | |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 1.03e-04 | 62 | 150 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.06e-04 | 33 | 150 | 4 | GO:0072349 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 1.42e-04 | 105 | 150 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | complement receptor activity | 1.42e-04 | 14 | 150 | 3 | GO:0004875 | |
| GeneOntologyMolecularFunction | nucleotide-sugar transmembrane transporter activity | 1.42e-04 | 14 | 150 | 3 | GO:0005338 | |
| GeneOntologyMolecularFunction | sodium:dicarboxylate symporter activity | 1.67e-04 | 3 | 150 | 2 | GO:0017153 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 1.67e-04 | 3 | 150 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 1.74e-04 | 109 | 150 | 6 | GO:0042626 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 2.74e-04 | 42 | 150 | 4 | GO:0042887 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 3.29e-04 | 44 | 150 | 4 | GO:0046915 | |
| GeneOntologyMolecularFunction | peptide:proton symporter activity | 3.33e-04 | 4 | 150 | 2 | GO:0015333 | |
| GeneOntologyMolecularFunction | amide binding | 4.41e-04 | 299 | 150 | 9 | GO:0033218 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.09e-04 | 133 | 150 | 6 | GO:0008528 | |
| GeneOntologyMolecularFunction | channel inhibitor activity | 5.39e-04 | 50 | 150 | 4 | GO:0016248 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 5.52e-04 | 5 | 150 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | scavenger receptor binding | 5.52e-04 | 5 | 150 | 2 | GO:0005124 | |
| GeneOntologyMolecularFunction | dipeptide transmembrane transporter activity | 5.52e-04 | 5 | 150 | 2 | GO:0071916 | |
| GeneOntologyMolecularFunction | N-formyl peptide receptor activity | 5.52e-04 | 5 | 150 | 2 | GO:0004982 | |
| GeneOntologyMolecularFunction | transporter inhibitor activity | 5.81e-04 | 51 | 150 | 4 | GO:0141110 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 6.59e-04 | 23 | 150 | 3 | GO:0005283 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 6.68e-04 | 140 | 150 | 6 | GO:0001653 | |
| GeneOntologyMolecularFunction | bile acid:sodium symporter activity | 8.24e-04 | 6 | 150 | 2 | GO:0008508 | |
| GeneOntologyMolecularFunction | succinate transmembrane transporter activity | 8.24e-04 | 6 | 150 | 2 | GO:0015141 | |
| GeneOntologyMolecularFunction | lactate transmembrane transporter activity | 8.24e-04 | 6 | 150 | 2 | GO:0015129 | |
| GeneOntologyMolecularFunction | folic acid transmembrane transporter activity | 8.24e-04 | 6 | 150 | 2 | GO:0008517 | |
| GeneOntologyMolecularFunction | solute:proton symporter activity | 8.46e-04 | 25 | 150 | 3 | GO:0015295 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 1.06e-03 | 27 | 150 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | hormone binding | 1.08e-03 | 103 | 150 | 5 | GO:0042562 | |
| GeneOntologyMolecularFunction | chloride channel inhibitor activity | 1.15e-03 | 7 | 150 | 2 | GO:0019869 | |
| GeneOntologyMolecularFunction | steroid hormone binding | 1.15e-03 | 7 | 150 | 2 | GO:1990239 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 1.32e-03 | 29 | 150 | 3 | GO:0005416 | |
| GeneOntologyMolecularFunction | copper ion transmembrane transporter activity | 1.52e-03 | 8 | 150 | 2 | GO:0005375 | |
| GeneOntologyMolecularFunction | dicarboxylic acid transmembrane transporter activity | 1.60e-03 | 31 | 150 | 3 | GO:0005310 | |
| GeneOntologyMolecularFunction | taste receptor activity | 1.92e-03 | 33 | 150 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | peptide transmembrane transporter activity | 1.95e-03 | 9 | 150 | 2 | GO:1904680 | |
| GeneOntologyMolecularFunction | channel regulator activity | 2.04e-03 | 174 | 150 | 6 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 2.23e-03 | 177 | 150 | 6 | GO:0141108 | |
| GeneOntologyMolecularFunction | primary active transmembrane transporter activity | 2.29e-03 | 178 | 150 | 6 | GO:0015399 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | CACNA1A CACNA1D CACNA1E CACNA1F SLC12A8 SLC46A1 SLC15A3 SLC1A3 SLC5A1 SLC12A5 SLC7A8 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SLC15A1 SLC22A4 KCNJ12 SCN5A SLC39A6 CACNA1I CACNA1H CACNA1G KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 | 1.89e-26 | 230 | 149 | 28 | GO:0098739 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CYBB CACNA1A CACNA1D CACNA1E CACNA1F ANO9 ATP7A HTR2A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC4A3 SLC22A17 EDNRB CALHM2 SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 P2RX6 CLDN17 SLC22A4 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 TMC8 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G MFSD8 SLC5A8 KCNJ18 ATP1A1 ATP1A3 TMEM109 SLC12A7 ATP2B4 SLC39A7 | 2.98e-25 | 1374 | 149 | 53 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CYBB CACNA1A CACNA1D CACNA1E CACNA1F ANO9 ATP7A HTR2A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC4A3 EDNRB CALHM2 SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SLC15A1 P2RX6 CLDN17 KCNJ12 SCN4A SCN5A SCN9A TMC8 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G MFSD8 KCNJ18 ATP1A1 ATP1A3 TMEM109 SLC12A7 ATP2B4 SLC39A7 | 9.52e-25 | 1115 | 149 | 48 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1A CACNA1D CACNA1E CACNA1F ANO9 ATP7A HTR2A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC4A3 RHAG EDNRB SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SLC15A1 P2RX6 CLDN17 KCNJ12 SCN4A SCN5A SCN9A SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G MFSD8 SLC5A8 KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 | 1.49e-24 | 1017 | 149 | 46 | GO:0098660 |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | CACNA1A CACNA1D CACNA1E CACNA1F SLC12A8 SLC5A1 SLC12A5 SLC8A1 SLC8A3 SLC9A1 SLC12A3 KCNJ12 SCN5A SLC39A6 CACNA1I CACNA1H CACNA1G KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 | 2.72e-23 | 142 | 149 | 22 | GO:0099587 |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | CACNA1A CACNA1D CACNA1E CACNA1F SLC12A8 SLC5A1 SLC12A5 SLC8A1 SLC8A3 SLC9A1 SLC12A3 KCNJ12 SCN5A SLC39A6 CACNA1I CACNA1H CACNA1G KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 | 2.72e-23 | 142 | 149 | 22 | GO:0098659 |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC22A17 EDNRB CALHM2 SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 P2RX6 SLC22A4 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G SLC5A8 KCNJ18 ATP1A1 ATP1A3 TMEM109 SLC12A7 ATP2B4 SLC39A7 | 3.89e-23 | 1157 | 149 | 47 | GO:0006812 |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC13A2 SLC1A3 SLC22A17 EDNRB CALHM2 SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 P2RX6 SLC22A4 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G SLC5A8 KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 | 5.87e-23 | 1000 | 149 | 44 | GO:0030001 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 EDNRB CALHM2 SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SLC15A1 P2RX6 KCNJ12 SCN4A SCN5A SCN9A SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G KCNJ18 ATP1A1 ATP1A3 TMEM109 SLC12A7 ATP2B4 SLC39A7 | 4.30e-22 | 942 | 149 | 42 | GO:0098655 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A ATP7B SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC13A2 SLC1A3 RHAG EDNRB SLC5A1 SLC12A5 SLC41A2 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SLC15A1 P2RX6 KCNJ12 SCN4A SCN5A SCN9A SLC39A6 ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G KCNJ18 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 | 1.65e-21 | 922 | 149 | 41 | GO:0098662 |
| GeneOntologyBiologicalProcess | sodium ion transport | SLC6A15 SLC13A2 EDNRB SLC5A1 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC22A4 SCN4A SCN5A SCN9A SLC10A6 SLC13A5 CACNA1I CACNA1H CACNA1G SLC5A8 ATP1A1 ATP1A3 ATP2B4 | 4.12e-18 | 275 | 149 | 23 | GO:0006814 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | SLC6A15 SLC13A2 SLC5A1 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SCN4A SCN5A SCN9A SLC13A5 CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 1.22e-14 | 208 | 149 | 18 | GO:0035725 |
| GeneOntologyBiologicalProcess | organic anion transport | CACNA1A SLC25A20 SLC19A3 SLC6A15 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC4A3 SLC16A12 RHAG CALHM2 SLC7A8 SLC6A12 SLC35A3 SLC10A2 SLC35A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 ATP1A3 PRAF2 SLC16A7 SLC35B1 | 4.46e-14 | 515 | 149 | 25 | GO:0015711 |
| GeneOntologyBiologicalProcess | import into cell | CACNA1A CACNA1D CACNA1E CACNA1F FPR2 SLC12A8 SLC46A1 SLC15A3 SLC1A3 SLC5A1 SLC12A5 SLC7A8 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 CD9 SLC15A1 AGER SLC22A4 KCNJ12 SCN5A SLC39A6 CACNA1I CACNA1H CACNA1G KCNJ18 ATP1A1 ATP1A3 C9orf72 SLC12A7 ATP2B4 | 1.05e-12 | 1074 | 149 | 33 | GO:0098657 |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | CACNA1A CACNA1D CACNA1E CACNA1F SLC8A1 SLC8A3 CACNA1I CACNA1H CACNA1G ATP2B4 | 1.47e-12 | 48 | 149 | 10 | GO:0098703 |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | CACNA1A CACNA1D CACNA1E CACNA1F SLC8A1 SLC8A3 CACNA1I CACNA1H CACNA1G ATP2B4 | 1.47e-12 | 48 | 149 | 10 | GO:1902656 |
| GeneOntologyBiologicalProcess | inorganic ion homeostasis | CACNA1A CACNA1F ATP7A HTR2A ATP7B SLC12A8 SLC46A1 SLC1A3 SLC22A17 RHAG EDNRB SLC12A5 SLC8A1 SLC8A3 SLC9A1 SLC12A3 TMC8 SLC39A6 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 HCRTR2 | 1.97e-11 | 622 | 149 | 24 | GO:0098771 |
| GeneOntologyBiologicalProcess | monoatomic cation homeostasis | CACNA1A CACNA1F ATP7A HTR2A ATP7B SLC12A8 SLC46A1 SLC1A3 SLC4A3 SLC22A17 RHAG EDNRB SLC12A5 SLC8A1 SLC8A3 SLC9A1 SLC12A3 TMC8 SLC39A6 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 HCRTR2 | 4.36e-11 | 705 | 149 | 25 | GO:0055080 |
| GeneOntologyBiologicalProcess | heart contraction | CACNA1D CACNA1E CHRM3 SLC4A3 EDNRB SLC8A1 SLC8A3 SLC9A1 KCNJ12 SCN4A SCN5A SCN9A CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 5.70e-11 | 298 | 149 | 17 | GO:0060047 |
| GeneOntologyBiologicalProcess | monoatomic ion homeostasis | CACNA1A CACNA1F ATP7A HTR2A ATP7B SLC12A8 SLC46A1 SLC1A3 SLC4A3 SLC22A17 RHAG EDNRB SLC12A5 SLC8A1 SLC8A3 SLC9A1 SLC12A3 TMC8 SLC39A6 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 HCRTR2 | 6.24e-11 | 717 | 149 | 25 | GO:0050801 |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A ATP7B SLC12A8 SLC46A1 SLC1A3 SLC4A3 SLC22A17 RHAG SLC12A5 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 AGER TMC8 SLC39A6 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 HCRTR2 GPRC5B | 7.87e-11 | 981 | 149 | 29 | GO:0019725 |
| GeneOntologyBiologicalProcess | heart process | CACNA1D CACNA1E CHRM3 SLC4A3 EDNRB SLC8A1 SLC8A3 SLC9A1 KCNJ12 SCN4A SCN5A SCN9A CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 1.00e-10 | 309 | 149 | 17 | GO:0003015 |
| GeneOntologyBiologicalProcess | calcium ion import | CACNA1A CACNA1D CACNA1E CACNA1F CALHM2 SLC8A1 SLC8A3 CACNA1I CACNA1H CACNA1G ATP2B4 | 1.26e-10 | 98 | 149 | 11 | GO:0070509 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.56e-10 | 36 | 149 | 8 | GO:0086010 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | CACNA1D CACNA1E HTR2A CHRM3 SLC4A3 EDNRB SLC8A1 SLC8A3 SLC9A1 AGER KCNJ12 SCN5A CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 2.30e-10 | 326 | 149 | 17 | GO:1903522 |
| GeneOntologyBiologicalProcess | regulation of heart contraction | CACNA1D CACNA1E CHRM3 SLC4A3 EDNRB SLC8A1 SLC8A3 SLC9A1 KCNJ12 SCN5A CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 3.84e-10 | 249 | 149 | 15 | GO:0008016 |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1D CACNA1E HTR2A SLC1A3 CHRM3 SLC4A3 SLC16A12 EDNRB SLC5A1 SLC7A8 SLC8A1 SLC8A3 SLC9A1 AGER KCNJ12 SCN4A SCN5A SCN9A CACNA1H CACNA1G ATP1A1 ATP1A3 SLC16A7 ATP2B4 | 5.60e-10 | 733 | 149 | 24 | GO:0003013 |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A ATP7B SLC46A1 SLC1A3 SLC4A3 SLC22A17 RHAG SLC12A5 SLC6A12 SLC8A1 SLC8A3 SLC9A1 AGER TMC8 SLC39A6 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 HCRTR2 | 6.25e-10 | 866 | 149 | 26 | GO:0055082 |
| GeneOntologyBiologicalProcess | carboxylic acid transport | CACNA1A SLC25A20 SLC19A3 SLC6A15 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC16A12 SLC7A8 SLC6A12 SLC10A2 SLC10A6 SLC13A5 SLC5A8 ATP1A3 PRAF2 SLC16A7 | 1.05e-09 | 410 | 149 | 18 | GO:0046942 |
| GeneOntologyBiologicalProcess | organic acid transport | CACNA1A SLC25A20 SLC19A3 SLC6A15 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC16A12 SLC7A8 SLC6A12 SLC10A2 SLC10A6 SLC13A5 SLC5A8 ATP1A3 PRAF2 SLC16A7 | 1.14e-09 | 412 | 149 | 18 | GO:0015849 |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1A CACNA1D CMKLR2 CACNA1E CACNA1F ATP7A HTR2A ATP7B SLC12A8 SLC46A1 SLC1A3 SLC4A3 SLC22A17 RHAG EDNRB SLC12A5 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 AGER TMC8 SLC39A6 ATP1A1 ATP1A3 SLC12A7 ATP2B4 SLC39A7 HCRTR2 GPRC5B | 1.17e-09 | 1249 | 149 | 31 | GO:0048878 |
| GeneOntologyBiologicalProcess | chloride transport | ANO9 SLC12A8 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC12A3 CLDN17 MFSD8 SLC5A8 SLC12A7 | 2.27e-09 | 128 | 149 | 11 | GO:0006821 |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | SLC25A20 SLC6A15 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC16A12 SLC7A8 SLC13A5 SLC5A8 PRAF2 SLC16A7 | 2.46e-09 | 163 | 149 | 12 | GO:1905039 |
| GeneOntologyBiologicalProcess | cardiac conduction | CACNA1D SLC4A3 SLC8A1 SLC8A3 SLC9A1 SCN5A CACNA1G ATP1A1 ATP1A3 ATP2B4 | 2.84e-09 | 100 | 149 | 10 | GO:0061337 |
| GeneOntologyBiologicalProcess | potassium ion import across plasma membrane | 3.01e-09 | 51 | 149 | 8 | GO:1990573 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | SLC25A20 SLC6A15 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC16A12 SLC7A8 SLC13A5 SLC5A8 PRAF2 SLC16A7 | 3.25e-09 | 167 | 149 | 12 | GO:1903825 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | ANO9 SLC12A8 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC12A3 CLDN17 MFSD8 SLC5A8 SLC12A7 | 3.70e-09 | 134 | 149 | 11 | GO:0098661 |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | CACNA1A CACNA1F ATP7A HTR2A ATP7B SLC46A1 SLC1A3 SLC4A3 SLC22A17 RHAG SLC12A5 SLC8A1 SLC8A3 SLC9A1 TMC8 SLC39A6 ATP1A1 ATP1A3 ATP2B4 SLC39A7 HCRTR2 | 4.38e-09 | 622 | 149 | 21 | GO:0006873 |
| GeneOntologyBiologicalProcess | muscle contraction | CACNA1D HTR2A CHRM3 EDNRB SLC8A1 SLC8A3 SLC9A1 P2RX6 KCNJ12 SCN4A SCN5A SCN9A CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 5.13e-09 | 400 | 149 | 17 | GO:0006936 |
| GeneOntologyBiologicalProcess | organic cation transport | CACNA1A SLC25A20 SLC19A3 SLC44A2 SLC6A15 SLC7A6 RHAG SLC7A8 SLC6A12 SLC22A4 SCN4A | 8.52e-09 | 145 | 149 | 11 | GO:0015695 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | ANO9 SLC12A8 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC12A3 CLDN17 MFSD8 SLC12A7 | 8.61e-09 | 112 | 149 | 10 | GO:1902476 |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | CACNA1A CACNA1F ATP7A HTR2A ATP7B SLC46A1 SLC1A3 SLC4A3 SLC22A17 SLC12A5 SLC8A1 SLC8A3 SLC9A1 TMC8 SLC39A6 ATP1A1 ATP1A3 ATP2B4 SLC39A7 HCRTR2 | 1.77e-08 | 611 | 149 | 20 | GO:0030003 |
| GeneOntologyBiologicalProcess | membrane depolarization | CACNA1A CACNA1D SLC8A1 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G ATP1A3 | 1.82e-08 | 121 | 149 | 10 | GO:0051899 |
| GeneOntologyBiologicalProcess | modified amino acid transport | 2.73e-08 | 44 | 149 | 7 | GO:0072337 | |
| GeneOntologyBiologicalProcess | sodium ion homeostasis | 7.91e-08 | 51 | 149 | 7 | GO:0055078 | |
| GeneOntologyBiologicalProcess | inorganic anion transport | ANO9 SLC12A8 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC12A3 CLDN17 MFSD8 SLC5A8 SLC12A7 | 8.00e-08 | 180 | 149 | 11 | GO:0015698 |
| GeneOntologyBiologicalProcess | potassium ion transport | CACNA1D HTR2A SLC12A8 SLC1A3 SLC12A5 SLC9A1 SLC12A3 KCNJ12 SCN4A KCNJ18 ATP1A1 ATP1A3 SLC12A7 | 9.29e-08 | 272 | 149 | 13 | GO:0006813 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | ANO9 SLC12A8 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC12A3 CLDN17 MFSD8 SLC5A8 SLC12A7 | 9.47e-08 | 183 | 149 | 11 | GO:0006820 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | CACNA1A CACNA1E SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G ATP1A3 | 1.23e-07 | 112 | 149 | 9 | GO:0019226 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A EDNRB SLC8A1 SLC8A3 SLC9A1 P2RX6 ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 1.69e-07 | 392 | 149 | 15 | GO:0070588 |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | ANO9 SLC12A8 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC12A3 CLDN17 MFSD8 SLC12A7 | 1.70e-07 | 153 | 149 | 10 | GO:0098656 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 2.22e-07 | 87 | 149 | 8 | GO:0086001 | |
| GeneOntologyBiologicalProcess | transport across blood-brain barrier | 2.22e-07 | 87 | 149 | 8 | GO:0150104 | |
| GeneOntologyBiologicalProcess | blood circulation | CACNA1D CACNA1E HTR2A CHRM3 SLC4A3 EDNRB SLC8A1 SLC8A3 SLC9A1 AGER KCNJ12 SCN4A SCN5A SCN9A CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 2.30e-07 | 648 | 149 | 19 | GO:0008015 |
| GeneOntologyBiologicalProcess | vascular transport | 2.42e-07 | 88 | 149 | 8 | GO:0010232 | |
| GeneOntologyBiologicalProcess | action potential | CACNA1D SLC4A3 SLC8A1 SLC9A1 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G ATP1A1 | 2.45e-07 | 201 | 149 | 11 | GO:0001508 |
| GeneOntologyBiologicalProcess | potassium ion homeostasis | 2.48e-07 | 37 | 149 | 6 | GO:0055075 | |
| GeneOntologyBiologicalProcess | UDP-galactose transmembrane transport | 3.69e-07 | 3 | 149 | 3 | GO:0072334 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 3.72e-07 | 93 | 149 | 8 | GO:0086003 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | CACNA1D SLC8A1 SLC9A1 SCN4A SCN5A SCN9A CACNA1H CACNA1G ATP1A1 ATP1A3 | 3.84e-07 | 167 | 149 | 10 | GO:0060048 |
| GeneOntologyBiologicalProcess | muscle system process | CACNA1D HTR2A CHRM3 EDNRB SLC8A1 SLC8A3 SLC9A1 P2RX6 KCNJ12 SCN4A SCN5A SCN9A CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 4.68e-07 | 547 | 149 | 17 | GO:0003012 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A SLC8A1 SLC8A3 CACNA1I CACNA1H CACNA1G ATP2B4 | 5.26e-07 | 217 | 149 | 11 | GO:0097553 |
| GeneOntologyBiologicalProcess | striated muscle contraction | CACNA1D SLC8A1 SLC8A3 SLC9A1 SCN4A SCN5A SCN9A CACNA1H CACNA1G ATP1A1 ATP1A3 | 5.26e-07 | 217 | 149 | 11 | GO:0006941 |
| GeneOntologyBiologicalProcess | cell volume homeostasis | 5.44e-07 | 42 | 149 | 6 | GO:0006884 | |
| GeneOntologyBiologicalProcess | positive regulation of cytosolic calcium ion concentration | CACNA1A HTR2A CCR9 FPR1 FPR2 EDNRB SLC8A1 SLC8A3 CACNA1I CACNA1G C5AR1 | 7.20e-07 | 224 | 149 | 11 | GO:0007204 |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 8.70e-07 | 25 | 149 | 5 | GO:0055064 | |
| GeneOntologyBiologicalProcess | calcium ion transport | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A EDNRB CALHM2 SLC8A1 SLC8A3 SLC9A1 P2RX6 ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 8.96e-07 | 509 | 149 | 16 | GO:0006816 |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | CACNA1D SLC12A8 SLC1A3 SLC12A5 SLC9A1 SLC12A3 KCNJ12 KCNJ18 ATP1A1 ATP1A3 SLC12A7 | 1.02e-06 | 232 | 149 | 11 | GO:0071805 |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | HTR2A SLC1A3 CHRM3 SLC4A3 SLC16A12 EDNRB SLC5A1 SLC7A8 SLC8A1 AGER CACNA1G SLC16A7 ATP2B4 | 1.34e-06 | 344 | 149 | 13 | GO:0003018 |
| GeneOntologyBiologicalProcess | regulation of system process | CACNA1D CACNA1E HTR2A CHRM3 SLC4A3 EDNRB SLC8A1 SLC8A3 SLC9A1 NRXN2 AGER KCNJ12 SCN4A SCN5A CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 1.50e-06 | 734 | 149 | 19 | GO:0044057 |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 1.58e-06 | 28 | 149 | 5 | GO:0055081 | |
| GeneOntologyBiologicalProcess | behavior | CACNA1A CACNA1E ATP7A HTR2A CWH43 SLC1A3 EDNRB SLC12A5 SLC8A3 AAAS TAS2R5 NRXN2 UCHL1 AGER SCN9A MRGPRX4 MFSD8 ATP1A3 VPS13B HCRTR2 GPRC5B | 1.79e-06 | 891 | 149 | 21 | GO:0007610 |
| GeneOntologyBiologicalProcess | intracellular sodium ion homeostasis | 2.27e-06 | 30 | 149 | 5 | GO:0006883 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | CACNA1D CMKLR2 OR5B3 OR5T3 HTR2A GPR25 OR4N5 OR4D10 CCR9 FPR1 FPR2 OR4D1 CHRM3 GPR179 EDNRB TAS2R9 TAS2R5 GPR61 SORCS2 MRGPRX4 OR4C12 TAS2R41 C5AR1 ATP2B4 OR4A4P HCRTR2 GPRC5B | 2.33e-06 | 1395 | 149 | 27 | GO:0007186 |
| GeneOntologyBiologicalProcess | amino-acid betaine transport | 2.47e-06 | 14 | 149 | 4 | GO:0015838 | |
| GeneOntologyBiologicalProcess | vascular associated smooth muscle contraction | 2.69e-06 | 31 | 149 | 5 | GO:0014829 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | CACNA1A CACNA1D SLC4A3 SLC8A1 SLC8A3 SLC9A1 P2RX6 SCN4A SCN5A SCN9A TSPAN4 CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 | 3.01e-06 | 559 | 149 | 16 | GO:0042391 |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 3.66e-06 | 5 | 149 | 3 | GO:0086046 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 3.99e-06 | 127 | 149 | 8 | GO:0070252 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 4.22e-06 | 59 | 149 | 6 | GO:0086065 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 5.66e-06 | 62 | 149 | 6 | GO:0086002 | |
| GeneOntologyBiologicalProcess | sodium ion export across plasma membrane | 5.79e-06 | 17 | 149 | 4 | GO:0036376 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 6.22e-06 | 63 | 149 | 6 | GO:0019228 | |
| GeneOntologyBiologicalProcess | quaternary ammonium group transport | 9.32e-06 | 19 | 149 | 4 | GO:0015697 | |
| GeneOntologyBiologicalProcess | amino acid transport | CACNA1A SLC6A15 SLC7A6 SLC1A3 SLC7A8 SLC6A12 SLC15A1 SLC22A4 PRAF2 | 1.25e-05 | 195 | 149 | 9 | GO:0006865 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.57e-05 | 153 | 149 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | regulation of striated muscle contraction | 1.62e-05 | 111 | 149 | 7 | GO:0006942 | |
| GeneOntologyBiologicalProcess | transition metal ion transport | 1.82e-05 | 113 | 149 | 7 | GO:0000041 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 2.08e-05 | 23 | 149 | 4 | GO:0086012 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 2.68e-05 | 120 | 149 | 7 | GO:0003333 | |
| GeneOntologyBiologicalProcess | sodium ion import across plasma membrane | 4.03e-05 | 27 | 149 | 4 | GO:0098719 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 4.27e-05 | 129 | 149 | 7 | GO:0002027 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 4.27e-05 | 10 | 149 | 3 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 4.27e-05 | 10 | 149 | 3 | GO:0086015 | |
| GeneOntologyBiologicalProcess | L-leucine transport | 4.27e-05 | 10 | 149 | 3 | GO:0015820 | |
| GeneOntologyBiologicalProcess | export across plasma membrane | 5.17e-05 | 91 | 149 | 6 | GO:0140115 | |
| GeneOntologyBiologicalProcess | fumarate transport | 5.18e-05 | 2 | 149 | 2 | GO:0015741 | |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 5.19e-05 | 133 | 149 | 7 | GO:0007200 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 5.84e-05 | 11 | 149 | 3 | GO:0086070 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle cell membrane potential | 5.84e-05 | 11 | 149 | 3 | GO:0086036 | |
| GeneOntologyCellularComponent | basal plasma membrane | ATP7A ATP7B SLC46A1 SLC1A3 CHRM3 SLC16A12 SLC7A8 SLC6A12 SLC8A1 SLC9A1 AGER SLC22A4 SLC13A5 C5AR1 ATP1A1 SLC16A7 ATP2B4 | 9.11e-10 | 354 | 152 | 17 | GO:0009925 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.55e-09 | 17 | 152 | 6 | GO:0001518 | |
| GeneOntologyCellularComponent | basal part of cell | ATP7A ATP7B SLC46A1 SLC1A3 CHRM3 SLC16A12 SLC7A8 SLC6A12 SLC8A1 SLC9A1 AGER SLC22A4 SLC13A5 C5AR1 ATP1A1 SLC16A7 ATP2B4 | 2.46e-09 | 378 | 152 | 17 | GO:0045178 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CYBB CACNA1A CACNA1D CACNA1E CACNA1F SLC9A1 CLDN17 KCNJ12 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G MFSD8 KCNJ18 ATP1A1 ATP1A3 TMEM109 | 8.90e-09 | 523 | 152 | 19 | GO:1902495 |
| GeneOntologyCellularComponent | basolateral plasma membrane | ATP7A ATP7B SLC46A1 SLC1A3 CHRM3 SLC16A12 SLC7A8 SLC6A12 SLC8A1 SLC9A1 SLC13A5 C5AR1 ATP1A1 SLC16A7 ATP2B4 | 1.30e-08 | 320 | 152 | 15 | GO:0016323 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CYBB CACNA1A CACNA1D CACNA1E CACNA1F CLDN17 KCNJ12 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G MFSD8 KCNJ18 TMEM109 | 1.75e-08 | 378 | 152 | 16 | GO:0034702 |
| GeneOntologyCellularComponent | transporter complex | CYBB CACNA1A CACNA1D CACNA1E CACNA1F SLC9A1 CLDN17 KCNJ12 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G MFSD8 KCNJ18 ATP1A1 ATP1A3 TMEM109 | 1.99e-08 | 550 | 152 | 19 | GO:1990351 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 3.95e-08 | 46 | 152 | 7 | GO:0005891 | |
| GeneOntologyCellularComponent | sodium channel complex | 5.54e-08 | 29 | 152 | 6 | GO:0034706 | |
| GeneOntologyCellularComponent | apical part of cell | CACNA1D ATP7A ATP7B SLC46A1 SLC13A2 SLC5A1 SLC7A8 SPTBN5 SLC9A1 SLC10A2 SLC12A3 CD9 SLC15A1 AGER SLC22A4 SLC39A6 C5AR1 SLC5A8 ATP1A1 | 6.37e-08 | 592 | 152 | 19 | GO:0045177 |
| GeneOntologyCellularComponent | T-tubule | 1.09e-07 | 79 | 152 | 8 | GO:0030315 | |
| GeneOntologyCellularComponent | sarcolemma | CACNA1D SLC8A1 SLC8A3 SLC9A1 KCNJ12 SCN5A CACNA1H KCNJ18 ATP1A1 ATP1A3 ATP2B4 | 1.49e-07 | 190 | 152 | 11 | GO:0042383 |
| GeneOntologyCellularComponent | neuronal cell body | CYBB CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A SLC1A3 SLC12A5 SLC8A1 SLC8A3 P2RX6 UCHL1 AGER KCNJ12 SORCS2 MRGPRX4 CACNA1H CACNA1G KCNJ18 ATP1A3 C9orf72 | 1.72e-07 | 835 | 152 | 22 | GO:0043025 |
| GeneOntologyCellularComponent | synaptic membrane | CACNA1A CACNA1D CACNA1E HTR2A ZDHHC17 CHRM3 GPR179 SLC12A5 SEMA4C SLC8A1 SLC8A3 NRXN2 P2RX6 SORCS2 CACNA1H ATP1A3 SLC16A7 ATP2B4 | 2.57e-07 | 583 | 152 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | apical plasma membrane | CACNA1D ATP7A SLC46A1 SLC13A2 SLC5A1 SLC7A8 SLC9A1 SLC10A2 SLC12A3 CD9 SLC15A1 AGER SLC22A4 SLC39A6 SLC5A8 ATP1A1 | 5.51e-07 | 487 | 152 | 16 | GO:0016324 |
| GeneOntologyCellularComponent | calcium channel complex | 1.02e-06 | 73 | 152 | 7 | GO:0034704 | |
| GeneOntologyCellularComponent | cell body | CYBB CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A SLC1A3 SLC12A5 SLC8A1 SLC8A3 P2RX6 UCHL1 AGER KCNJ12 SORCS2 MRGPRX4 CACNA1H CACNA1G KCNJ18 ATP1A3 C9orf72 | 1.04e-06 | 929 | 152 | 22 | GO:0044297 |
| GeneOntologyCellularComponent | somatodendritic compartment | CYBB CACNA1A CACNA1D CACNA1E CACNA1F ATP7A HTR2A CLIP2 SLC1A3 CHRM3 GPR179 SLC12A5 SLC8A1 SLC8A3 P2RX6 UCHL1 AGER KCNJ12 SORCS2 MRGPRX4 CACNA1H CACNA1G KCNJ18 ATP1A3 C9orf72 | 2.76e-06 | 1228 | 152 | 25 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | CYBB CACNA1A CACNA1D ATP7A HTR2A CLIP2 SLC1A3 CHRM3 GPR179 SLC12A5 SLC8A1 SLC8A3 P2RX6 KCNJ12 SORCS2 CACNA1H CACNA1G KCNJ18 ATP1A3 C9orf72 | 4.27e-06 | 858 | 152 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CYBB CACNA1A CACNA1D ATP7A HTR2A CLIP2 SLC1A3 CHRM3 GPR179 SLC12A5 SLC8A1 SLC8A3 P2RX6 KCNJ12 SORCS2 CACNA1H CACNA1G KCNJ18 ATP1A3 C9orf72 | 4.42e-06 | 860 | 152 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | perikaryon | CACNA1A CACNA1D CACNA1E CACNA1F ATP7A SLC12A5 SLC8A3 SORCS2 CACNA1H C9orf72 | 5.59e-06 | 223 | 152 | 10 | GO:0043204 |
| GeneOntologyCellularComponent | postsynaptic membrane | CACNA1A CACNA1E HTR2A CHRM3 GPR179 SLC12A5 SEMA4C SLC8A1 SLC8A3 P2RX6 SORCS2 CACNA1H SLC16A7 | 8.60e-06 | 405 | 152 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | cation channel complex | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G | 8.86e-06 | 235 | 152 | 10 | GO:0034703 |
| GeneOntologyCellularComponent | postsynapse | CACNA1A CACNA1E ATP7A HTR2A ZDHHC17 SLC1A3 CHRM3 GPR179 SLC12A5 SEMA4C SLC8A1 SLC8A3 P2RX6 AGER SORCS2 CACNA1H ATP1A1 ATP1A3 PRAF2 C9orf72 SLC16A7 | 1.56e-05 | 1018 | 152 | 21 | GO:0098794 |
| GeneOntologyCellularComponent | membrane protein complex | CYBB CACNA1A CACNA1D CACNA1E CACNA1F AP5S1 TRAV6 SLC1A3 RHAG SLC9A1 CLDN17 ALG14 KCNJ12 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G MFSD8 KCNJ18 ATP1A1 ATP1A3 TMEM109 STX7 TRAV34 | 2.88e-05 | 1498 | 152 | 26 | GO:0098796 |
| GeneOntologyCellularComponent | presynaptic membrane | CACNA1A CACNA1D CACNA1E HTR2A ZDHHC17 CHRM3 NRXN2 CACNA1H ATP1A3 ATP2B4 | 3.65e-05 | 277 | 152 | 10 | GO:0042734 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | CYBB TMEM67 AP5S1 ATP7A FPR1 FPR2 SLC44A2 SLC46A1 ZDHHC17 SLC15A3 SNX19 SEMA4C GPR61 CD9 STOML1 SORCS2 MFSD8 C5AR1 STARD3NL PRAF2 STX7 VPS13B GPRC5B | 7.18e-05 | 1307 | 152 | 23 | GO:0030659 |
| GeneOntologyCellularComponent | vesicle membrane | CYBB TMEM67 AP5S1 ATP7A FPR1 FPR2 SLC44A2 SLC46A1 ZDHHC17 SLC15A3 SNX19 SEMA4C GPR61 CD9 STOML1 SORCS2 MFSD8 C5AR1 STARD3NL PRAF2 STX7 VPS13B GPRC5B | 8.82e-05 | 1325 | 152 | 23 | GO:0012506 |
| GeneOntologyCellularComponent | presynapse | CACNA1A CACNA1D CACNA1E HTR2A ZDHHC17 CHRM3 SEMA4C SLC6A12 SLC8A1 SLC8A3 NRXN2 CACNA1H ATP1A3 PRAF2 C9orf72 STX7 ATP2B4 | 2.53e-04 | 886 | 152 | 17 | GO:0098793 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.62e-04 | 78 | 152 | 5 | GO:0048787 | |
| GeneOntologyCellularComponent | photoreceptor inner segment membrane | 3.12e-04 | 4 | 152 | 2 | GO:0060342 | |
| GeneOntologyCellularComponent | endosome membrane | AP5S1 ATP7A SLC46A1 SLC15A3 SNX19 GPR61 STOML1 SORCS2 MFSD8 STARD3NL PRAF2 STX7 VPS13B | 4.67e-04 | 602 | 152 | 13 | GO:0010008 |
| GeneOntologyCellularComponent | plasma membrane protein complex | CYBB CACNA1A CACNA1D CACNA1E CACNA1F TRAV6 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 TRAV34 | 6.17e-04 | 785 | 152 | 15 | GO:0098797 |
| GeneOntologyCellularComponent | cell projection membrane | CACNA1D TMEM67 ATP7A SLC46A1 LCP1 SLC5A1 SLC12A5 SLC7A8 SLC39A6 SLC5A8 | 1.25e-03 | 431 | 152 | 10 | GO:0031253 |
| GeneOntologyCellularComponent | caveola | 1.31e-03 | 111 | 152 | 5 | GO:0005901 | |
| GeneOntologyCellularComponent | membrane raft | HTR2A SLC9A1 STOML1 SCN5A SLC39A6 CACNA1H ATP1A1 ATP2B4 GPRC5B | 1.36e-03 | 362 | 152 | 9 | GO:0045121 |
| GeneOntologyCellularComponent | membrane microdomain | HTR2A SLC9A1 STOML1 SCN5A SLC39A6 CACNA1H ATP1A1 ATP2B4 GPRC5B | 1.41e-03 | 364 | 152 | 9 | GO:0098857 |
| GeneOntologyCellularComponent | intercalated disc | 1.52e-03 | 68 | 152 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | bicellular tight junction | 2.72e-03 | 131 | 152 | 5 | GO:0005923 | |
| GeneOntologyCellularComponent | brush border membrane | 3.16e-03 | 83 | 152 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | sodium:potassium-exchanging ATPase complex | 3.30e-03 | 12 | 152 | 2 | GO:0005890 | |
| GeneOntologyCellularComponent | tight junction | 3.51e-03 | 139 | 152 | 5 | GO:0070160 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 3.56e-03 | 201 | 152 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | presynaptic active zone | 3.73e-03 | 141 | 152 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | postsynaptic specialization | ATP7A CHRM3 SLC12A5 SEMA4C SLC8A1 SLC8A3 P2RX6 SORCS2 ATP1A1 SLC16A7 | 3.82e-03 | 503 | 152 | 10 | GO:0099572 |
| GeneOntologyCellularComponent | cell-cell junction | ILDR2 ATP7B VSIG10 CLDN6 CLDN9 SLC5A1 SLC8A1 SLC9A1 CLDN17 SCN5A ATP1A1 | 4.02e-03 | 591 | 152 | 11 | GO:0005911 |
| GeneOntologyCellularComponent | vacuolar membrane | AP5S1 FPR1 SLC44A2 SLC15A3 SLC22A17 WDR11 MFSD8 STARD3NL STX7 VPS13B | 4.03e-03 | 507 | 152 | 10 | GO:0005774 |
| GeneOntologyCellularComponent | plasma membrane raft | 4.45e-03 | 147 | 152 | 5 | GO:0044853 | |
| GeneOntologyCellularComponent | endosome | AP5S1 ATP7A ATP7B SLC46A1 SLC15A3 SNX19 SLC5A1 GPR61 STOML1 SORCS2 MFSD8 STARD3NL ATP1A1 PRAF2 C9orf72 STX7 VPS13B | 4.92e-03 | 1167 | 152 | 17 | GO:0005768 |
| GeneOntologyCellularComponent | cell-cell contact zone | 4.94e-03 | 94 | 152 | 4 | GO:0044291 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | ATP7A CHRM3 SEMA4C SLC8A1 SLC8A3 SORCS2 ATP1A1 ATP1A3 C9orf72 SLC16A7 | 5.00e-03 | 523 | 152 | 10 | GO:0098984 |
| GeneOntologyCellularComponent | anchoring junction | ILDR2 ATP7B VSIG10 LCP1 CLDN6 CLDN9 SLC5A1 SLC8A1 SLC8A3 SLC9A1 CD9 CLDN17 SCN5A TSPAN4 ATP1A1 | 5.06e-03 | 976 | 152 | 15 | GO:0070161 |
| GeneOntologyCellularComponent | brush border | 5.12e-03 | 152 | 152 | 5 | GO:0005903 | |
| GeneOntologyCellularComponent | cation-transporting ATPase complex | 5.44e-03 | 49 | 152 | 3 | GO:0090533 | |
| GeneOntologyCellularComponent | axon | ATP7A HTR2A CHRM3 SLC8A1 SLC8A3 UCHL1 AGER SCN4A SCN5A SCN9A MRGPRX4 ATP1A1 ATP1A3 C9orf72 | 5.56e-03 | 891 | 152 | 14 | GO:0030424 |
| GeneOntologyCellularComponent | apical junction complex | 6.02e-03 | 158 | 152 | 5 | GO:0043296 | |
| GeneOntologyCellularComponent | lysosomal membrane | 6.78e-03 | 462 | 152 | 9 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 6.78e-03 | 462 | 152 | 9 | GO:0098852 | |
| GeneOntologyCellularComponent | ATPase dependent transmembrane transport complex | 7.50e-03 | 55 | 152 | 3 | GO:0098533 | |
| GeneOntologyCellularComponent | dendritic spine | 8.64e-03 | 242 | 152 | 6 | GO:0043197 | |
| HumanPheno | Ocular flutter | 2.08e-07 | 6 | 57 | 4 | HP:0031931 | |
| HumanPheno | Episodic hemiplegia | 5.27e-06 | 4 | 57 | 3 | HP:0012194 | |
| HumanPheno | Skewfoot | 2.59e-05 | 6 | 57 | 3 | HP:0032649 | |
| HumanPheno | Episodic hypokalemia | 2.59e-05 | 6 | 57 | 3 | HP:0012726 | |
| HumanPheno | Juvenile onset | CYBB CACNA1A ATP7A ATP7B SLC19A3 SLC4A3 SLC16A12 CLDN9 SLC12A5 AAAS SLC12A3 WDR11 UCHL1 SCN4A SCN5A SCN9A CACNA1H MFSD8 ATP1A1 ATP1A3 | 3.59e-05 | 700 | 57 | 20 | HP:0003621 |
| HumanPheno | Abnormal T-wave | 4.87e-05 | 37 | 57 | 5 | HP:0005135 | |
| HumanPheno | Abnormal nervous system electrophysiology | CACNA1A CACNA1E TMEM67 ATP7A HTR2A ATP7B AIMP2 MAP3K20 SLC1A3 EDNRB SLC12A5 AAAS UCHL1 ALG14 SCN4A SLC35A2 SCN9A SLC13A5 CACNA1H CACNA1G MFSD8 KCNJ18 ATP1A3 | 6.77e-05 | 924 | 57 | 23 | HP:0001311 |
| HumanPheno | Saccadic oscillation | 7.32e-05 | 21 | 57 | 4 | HP:0032104 | |
| HumanPheno | Abnormal autonomic nervous system physiology | 8.37e-05 | 130 | 57 | 8 | HP:0012332 | |
| HumanPheno | Postprandial hyperglycemia | 1.06e-04 | 9 | 57 | 3 | HP:0011998 | |
| HumanPheno | Abnormal EKG | 1.15e-04 | 136 | 57 | 8 | HP:0003115 | |
| HumanPheno | Episodic generalized hypotonia | 1.23e-04 | 2 | 57 | 2 | HP:0006852 | |
| HumanPheno | EEG with generalized epileptiform discharges | CACNA1A CACNA1E ATP7A AIMP2 SLC12A5 ALG14 SLC35A2 SCN9A SLC13A5 CACNA1H ATP1A3 | 1.57e-04 | 270 | 57 | 11 | HP:0011198 |
| HumanPheno | Interictal epileptiform activity | CACNA1A CACNA1E ATP7A AIMP2 SLC12A5 ALG14 SLC35A2 SCN9A SLC13A5 CACNA1H CACNA1G ATP1A3 | 1.62e-04 | 319 | 57 | 12 | HP:0011182 |
| HumanPheno | Hypsarrhythmia | CACNA1A CACNA1E ATP7A AIMP2 SLC12A5 ALG14 SLC35A2 SLC13A5 ATP1A3 | 1.80e-04 | 185 | 57 | 9 | HP:0002521 |
| HumanPheno | Exotropia | 1.85e-04 | 109 | 57 | 7 | HP:0000577 | |
| HumanPheno | Interictal EEG abnormality | CACNA1A CACNA1E ATP7A AIMP2 SLC12A5 ALG14 SLC35A2 SCN9A SLC13A5 CACNA1H CACNA1G ATP1A3 | 1.93e-04 | 325 | 57 | 12 | HP:0025373 |
| HumanPheno | Hypokalemia | 2.22e-04 | 79 | 57 | 6 | HP:0002900 | |
| HumanPheno | Tetraplegia/tetraparesis | 2.39e-04 | 151 | 57 | 8 | HP:0030182 | |
| HumanPheno | Abnormality of central nervous system electrophysiology | CACNA1A CACNA1E TMEM67 ATP7A HTR2A AIMP2 SLC1A3 EDNRB SLC12A5 AAAS UCHL1 ALG14 SLC35A2 SCN9A SLC13A5 CACNA1H CACNA1G MFSD8 ATP1A3 | 2.54e-04 | 738 | 57 | 19 | HP:0030178 |
| HumanPheno | Abnormal blood monovalent inorganic cation concentration | 2.73e-04 | 154 | 57 | 8 | HP:0010930 | |
| HumanPheno | Tetraparesis | 2.88e-04 | 117 | 57 | 7 | HP:0002273 | |
| HumanPheno | Abnormality of the autonomic nervous system | CACNA1A TMEM67 SLC25A20 ATP7A SLC1A3 EDNRB AAAS UCHL1 SCN5A SCN9A TMEM218 ATP1A3 | 3.46e-04 | 346 | 57 | 12 | HP:0002270 |
| MousePheno | abnormal channel response | 8.74e-06 | 33 | 121 | 5 | MP:0003484 | |
| MousePheno | neurodegeneration | CACNA1A CACNA1D CACNA1F ATP7B SLC19A3 SLC1A3 EDNRB CLDN9 SLC7A8 SLC8A3 SLC9A1 UCHL1 CACNA1G MFSD8 SLC12A7 | 1.24e-05 | 468 | 121 | 15 | MP:0002229 |
| MousePheno | impaired coordination | CYBB CACNA1A ATP7A CWH43 CLIP2 CCR9 ZDHHC17 SLC7A8 SLC8A3 UCHL1 SCN4A CACNA1G ATP1A3 C9orf72 VPS13B | 1.59e-05 | 478 | 121 | 15 | MP:0001405 |
| MousePheno | abnormal action potential | 1.99e-05 | 133 | 121 | 8 | MP:0005402 | |
| MousePheno | neuron degeneration | CACNA1A CACNA1D CACNA1F ATP7B SLC1A3 EDNRB CLDN9 SLC7A8 SLC9A1 UCHL1 CACNA1G MFSD8 SLC12A7 | 3.35e-05 | 391 | 121 | 13 | MP:0003224 |
| MousePheno | abnormal seizure response to pharmacological agent | 4.08e-05 | 147 | 121 | 8 | MP:0000950 | |
| MousePheno | abnormal seizure response to inducing agent | CACNA1A SLC1A3 SLC4A3 SLC12A5 SLC7A8 P2RX6 SCN9A CACNA1G ATP1A3 | 6.19e-05 | 201 | 121 | 9 | MP:0009357 |
| MousePheno | seizures | CACNA1A ATP7A SLC1A3 SLC4A3 SLC12A5 SLC7A8 SLC9A1 P2RX6 SCN5A SCN9A CACNA1G ATP1A3 | 6.67e-05 | 360 | 121 | 12 | MP:0002064 |
| MousePheno | abnormal kidney copper level | 7.43e-05 | 2 | 121 | 2 | MP:0010242 | |
| MousePheno | increased kidney copper level | 7.43e-05 | 2 | 121 | 2 | MP:0010243 | |
| MousePheno | hemiplegia | 7.43e-05 | 2 | 121 | 2 | MP:0031202 | |
| MousePheno | increased brain copper level | 7.43e-05 | 2 | 121 | 2 | MP:0011214 | |
| MousePheno | hypoalgesia | 1.14e-04 | 170 | 121 | 8 | MP:0003043 | |
| MousePheno | abnormal motor coordination/balance | CYBB CACNA1A ATP7A ATP7B CWH43 CLIP2 CCR9 ZDHHC17 SLC1A3 SLC7A8 SLC8A3 SLC9A1 AAAS UCHL1 SCN4A CACNA1G ATP1A3 C9orf72 VPS13B | 1.74e-04 | 873 | 121 | 19 | MP:0001516 |
| MousePheno | abnormal kindling response | 2.15e-04 | 14 | 121 | 3 | MP:0001499 | |
| MousePheno | decreased liver copper level | 2.22e-04 | 3 | 121 | 2 | MP:0003067 | |
| MousePheno | decreased circulating copper level | 2.22e-04 | 3 | 121 | 2 | MP:0006349 | |
| MousePheno | absence seizures | 2.27e-04 | 35 | 121 | 4 | MP:0003216 | |
| MousePheno | cochlear hair cell degeneration | 3.13e-04 | 106 | 121 | 6 | MP:0004362 | |
| MousePheno | abnormal behavioral response to xenobiotic | CACNA1A SLC1A3 SLC4A3 SLC12A5 SLC7A8 P2RX6 SORCS2 CACNA1G ATP1A1 ATP1A3 | 3.50e-04 | 309 | 121 | 10 | MP:0009745 |
| MousePheno | nonconvulsive seizures | 3.84e-04 | 40 | 121 | 4 | MP:0000948 | |
| MousePheno | increased copper level | 4.41e-04 | 4 | 121 | 2 | MP:0014539 | |
| MousePheno | abnormal circulating copper level | 4.41e-04 | 4 | 121 | 2 | MP:0006348 | |
| MousePheno | abnormal pH regulation | 4.64e-04 | 42 | 121 | 4 | MP:0004043 | |
| Domain | VDCCAlpha1 | 1.82e-13 | 10 | 146 | 7 | IPR002077 | |
| Domain | Channel_four-helix_dom | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G | 1.97e-11 | 57 | 146 | 10 | IPR027359 |
| Domain | - | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G | 1.97e-11 | 57 | 146 | 10 | 1.20.120.350 |
| Domain | TM4_1 | 8.97e-10 | 26 | 146 | 7 | PS00421 | |
| Domain | Tetraspanin | 4.41e-09 | 32 | 146 | 7 | IPR000301 | |
| Domain | Tetraspanin_EC2 | 4.41e-09 | 32 | 146 | 7 | IPR008952 | |
| Domain | Tetraspannin | 5.56e-09 | 33 | 146 | 7 | PF00335 | |
| Domain | Tetraspanin/Peripherin | 5.56e-09 | 33 | 146 | 7 | IPR018499 | |
| Domain | MFS_dom | MFSD11 SLC19A3 SLC46A1 SPNS3 SLC15A3 SLC22A17 SLC16A12 SLC15A1 SLC22A4 MFSD8 SLC16A7 | 8.23e-09 | 134 | 146 | 11 | IPR020846 |
| Domain | Tetraspanin_CS | 1.01e-08 | 21 | 146 | 6 | IPR018503 | |
| Domain | AA-permease/SLC12A_dom | 1.39e-08 | 22 | 146 | 6 | IPR004841 | |
| Domain | AA_permease | 1.39e-08 | 22 | 146 | 6 | PF00324 | |
| Domain | Ion_trans_dom | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G | 2.13e-08 | 114 | 146 | 10 | IPR005821 |
| Domain | Ion_trans | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G | 2.13e-08 | 114 | 146 | 10 | PF00520 |
| Domain | VDCC_a1su_IQ | 1.23e-07 | 7 | 146 | 4 | IPR014873 | |
| Domain | GPHH | 1.23e-07 | 7 | 146 | 4 | PF16905 | |
| Domain | GPHH_dom | 1.23e-07 | 7 | 146 | 4 | IPR031649 | |
| Domain | Ca_chan_IQ | 1.23e-07 | 7 | 146 | 4 | SM01062 | |
| Domain | Ca_chan_IQ | 1.23e-07 | 7 | 146 | 4 | PF08763 | |
| Domain | VDCC_T_a1 | 4.68e-07 | 3 | 146 | 3 | IPR005445 | |
| Domain | GPCR_Rhodpsn_7TM | CMKLR2 OR5B3 OR5T3 HTR2A GPR25 OR4N5 OR4D10 CCR9 FPR1 FPR2 OR4D1 CHRM3 EDNRB TAS2R9 GPR61 MRGPRX4 OR4C12 C5AR1 HCRTR2 | 1.22e-06 | 670 | 146 | 19 | IPR017452 |
| Domain | G_PROTEIN_RECEP_F1_2 | CMKLR2 OR5B3 OR5T3 HTR2A GPR25 OR4N5 OR4D10 CCR9 FPR1 FPR2 OR4D1 CHRM3 EDNRB TAS2R9 GPR61 MRGPRX4 OR4C12 C5AR1 HCRTR2 | 1.92e-06 | 691 | 146 | 19 | PS50262 |
| Domain | GPCR_Rhodpsn | CMKLR2 OR5B3 OR5T3 HTR2A GPR25 OR4N5 OR4D10 CCR9 FPR1 FPR2 OR4D1 CHRM3 EDNRB TAS2R9 GPR61 MRGPRX4 OR4C12 C5AR1 HCRTR2 | 1.96e-06 | 692 | 146 | 19 | IPR000276 |
| Domain | MFS_1 | 2.35e-06 | 77 | 146 | 7 | PF07690 | |
| Domain | MFS | 2.35e-06 | 77 | 146 | 7 | IPR011701 | |
| Domain | 7tm_1 | CMKLR2 OR5B3 OR5T3 HTR2A GPR25 OR4N5 OR4D10 CCR9 FPR1 FPR2 OR4D1 CHRM3 EDNRB GPR61 MRGPRX4 OR4C12 C5AR1 HCRTR2 | 5.82e-06 | 677 | 146 | 18 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | CMKLR2 OR5B3 OR5T3 HTR2A GPR25 OR4N5 OR4D10 CCR9 FPR1 FPR2 OR4D1 CHRM3 EDNRB GPR61 MRGPRX4 OR4C12 C5AR1 HCRTR2 | 6.83e-06 | 685 | 146 | 18 | PS00237 |
| Domain | ATPase_P-typ_cyto_domN | 7.32e-06 | 35 | 146 | 5 | IPR023299 | |
| Domain | P_typ_ATPase | 8.45e-06 | 36 | 146 | 5 | IPR001757 | |
| Domain | ATPase_P-typ_P_site | 8.45e-06 | 36 | 146 | 5 | IPR018303 | |
| Domain | ATPASE_E1_E2 | 8.45e-06 | 36 | 146 | 5 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 9.71e-06 | 37 | 146 | 5 | IPR008250 | |
| Domain | E1-E2_ATPase | 9.71e-06 | 37 | 146 | 5 | PF00122 | |
| Domain | SLC12A_fam | 1.60e-05 | 7 | 146 | 3 | IPR004842 | |
| Domain | MFS | 2.23e-05 | 108 | 146 | 7 | PS50850 | |
| Domain | SLC12_C | 2.55e-05 | 8 | 146 | 3 | IPR018491 | |
| Domain | SLC12 | 2.55e-05 | 8 | 146 | 3 | PF03522 | |
| Domain | Na_channel_asu | 5.39e-05 | 10 | 146 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 5.39e-05 | 10 | 146 | 3 | IPR010526 | |
| Domain | Formyl_rcpt-rel | 5.39e-05 | 10 | 146 | 3 | IPR000826 | |
| Domain | Na_trans_assoc | 5.39e-05 | 10 | 146 | 3 | PF06512 | |
| Domain | HMA_Cu_ion-bd | 6.07e-05 | 2 | 146 | 2 | IPR006122 | |
| Domain | P-typ_ATPase_IB | 6.07e-05 | 2 | 146 | 2 | IPR027256 | |
| Domain | K_chnl_inward-rec_Kir2.2 | 6.07e-05 | 2 | 146 | 2 | IPR003272 | |
| Domain | - | 1.09e-04 | 32 | 146 | 4 | 3.40.1110.10 | |
| Domain | - | 1.09e-04 | 32 | 146 | 4 | 2.70.150.10 | |
| Domain | K_chnl_inward-rec_Kir_N | 1.81e-04 | 3 | 146 | 2 | IPR013673 | |
| Domain | IRK_N | 1.81e-04 | 3 | 146 | 2 | PF08466 | |
| Domain | Na_Ca_Ex | 1.81e-04 | 3 | 146 | 2 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 1.81e-04 | 3 | 146 | 2 | IPR032452 | |
| Domain | CAC1F_C | 1.81e-04 | 3 | 146 | 2 | IPR031688 | |
| Domain | Na/sul_symport_CS | 1.81e-04 | 3 | 146 | 2 | IPR031312 | |
| Domain | CAC1F_C | 1.81e-04 | 3 | 146 | 2 | PF16885 | |
| Domain | Na_Ca_ex_C | 1.81e-04 | 3 | 146 | 2 | PF16494 | |
| Domain | NA_SULFATE | 1.81e-04 | 3 | 146 | 2 | PS01271 | |
| Domain | Heavy-metal-associated_CS | 1.81e-04 | 3 | 146 | 2 | IPR017969 | |
| Domain | PTR2_1 | 1.81e-04 | 3 | 146 | 2 | PS01022 | |
| Domain | - | 2.43e-04 | 16 | 146 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_TM_dom | 2.43e-04 | 16 | 146 | 3 | IPR023298 | |
| Domain | ATPase_P-typ_cation-transptr_C | 2.94e-04 | 17 | 146 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 2.94e-04 | 17 | 146 | 3 | PF00689 | |
| Domain | Cation_ATPase_N | 3.50e-04 | 18 | 146 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 3.50e-04 | 18 | 146 | 3 | SM00831 | |
| Domain | Bilac:Na_transpt | 3.60e-04 | 4 | 146 | 2 | IPR004710 | |
| Domain | HMA | 3.60e-04 | 4 | 146 | 2 | PF00403 | |
| Domain | VDCC_L_a1su | 3.60e-04 | 4 | 146 | 2 | IPR005446 | |
| Domain | KCL_cotranspt | 3.60e-04 | 4 | 146 | 2 | IPR000076 | |
| Domain | HMA_2 | 3.60e-04 | 4 | 146 | 2 | PS50846 | |
| Domain | HMA_1 | 3.60e-04 | 4 | 146 | 2 | PS01047 | |
| Domain | PTR2_2 | 3.60e-04 | 4 | 146 | 2 | PS01023 | |
| Domain | HAD-like_dom | 3.86e-04 | 79 | 146 | 5 | IPR023214 | |
| Domain | ATPase_P-typ_cation-transptr_N | 4.14e-04 | 19 | 146 | 3 | IPR004014 | |
| Domain | POT_fam | 5.98e-04 | 5 | 146 | 2 | IPR000109 | |
| Domain | PTR2 | 5.98e-04 | 5 | 146 | 2 | PF00854 | |
| Domain | Na/sul_symport | 5.98e-04 | 5 | 146 | 2 | IPR001898 | |
| Domain | Na_sulph_symp | 5.98e-04 | 5 | 146 | 2 | PF00939 | |
| Domain | Nuc_sug_transpt | 5.98e-04 | 5 | 146 | 2 | IPR007271 | |
| Domain | - | 5.98e-04 | 5 | 146 | 2 | 1.10.1450.10 | |
| Domain | Nuc_sug_transp | 5.98e-04 | 5 | 146 | 2 | PF04142 | |
| Domain | CD81_LEL | 5.98e-04 | 5 | 146 | 2 | IPR028977 | |
| Domain | Claudin_CS | 6.46e-04 | 22 | 146 | 3 | IPR017974 | |
| Domain | CLAUDIN | 6.46e-04 | 22 | 146 | 3 | PS01346 | |
| Domain | Na_trans_cytopl | 8.92e-04 | 6 | 146 | 2 | PF11933 | |
| Domain | P-type_ATPase_IIC | 8.92e-04 | 6 | 146 | 2 | IPR005775 | |
| Domain | Na_trans_cytopl | 8.92e-04 | 6 | 146 | 2 | IPR024583 | |
| Domain | TAS2R | 1.07e-03 | 26 | 146 | 3 | PF05296 | |
| Domain | T2R | 1.07e-03 | 26 | 146 | 3 | IPR007960 | |
| Domain | BilAc:Na_symport/Acr3 | 1.24e-03 | 7 | 146 | 2 | IPR002657 | |
| Domain | SBF | 1.24e-03 | 7 | 146 | 2 | PF01758 | |
| Domain | HMA_dom | 1.24e-03 | 7 | 146 | 2 | IPR006121 | |
| Domain | Claudin | 1.33e-03 | 28 | 146 | 3 | IPR006187 | |
| Domain | Calx_beta | 1.65e-03 | 8 | 146 | 2 | SM00237 | |
| Domain | Sugar_transporter_CS | 1.97e-03 | 32 | 146 | 3 | IPR005829 | |
| Domain | Calx_beta | 2.11e-03 | 9 | 146 | 2 | IPR003644 | |
| Domain | NaCa_Exmemb | 2.11e-03 | 9 | 146 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 2.11e-03 | 9 | 146 | 2 | PF01699 | |
| Domain | Calx-beta | 2.11e-03 | 9 | 146 | 2 | PF03160 | |
| Domain | NA_SOLUT_SYMP_1 | 3.19e-03 | 11 | 146 | 2 | PS00456 | |
| Domain | PMP22_Claudin | 3.74e-03 | 40 | 146 | 3 | PF00822 | |
| Domain | NA_SOLUT_SYMP_2 | 3.80e-03 | 12 | 146 | 2 | PS00457 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC44A2 SLC6A15 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 RHAG SLC5A1 SLC12A5 SLC7A8 SLC41A2 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC12A3 SLC15A1 SLC22A4 SLC35A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 SLC12A7 SLC16A7 SLC39A7 | 7.66e-25 | 238 | 116 | 28 | MM15076 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC44A2 SLC6A15 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 RHAG SLC5A1 SLC12A5 SLC7A8 SLC41A2 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC12A3 SLC15A1 SLC22A4 SLC35A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 SLC12A7 SLC16A7 SLC39A7 | 2.74e-24 | 249 | 116 | 28 | M5988 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO9 ATP7A ATP7B SLC44A2 SLC6A15 SLC46A1 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 ABCA9 SLC22A17 RHAG SLC5A1 SLC12A5 SLC7A8 SLC41A2 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC12A3 SLC15A1 SLC22A4 SLC35A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 ATP1A1 ATP1A3 SLC12A7 SLC16A7 ATP2B4 SLC39A7 | 5.88e-21 | 681 | 116 | 37 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ANO9 ATP7A ATP7B SLC44A2 SLC6A15 SLC46A1 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 ABCA9 SLC22A17 RHAG SLC5A1 SLC12A5 SLC7A8 SLC41A2 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC12A3 SLC15A1 SLC22A4 SLC35A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 ATP1A1 ATP1A3 SLC12A7 SLC16A7 ATP2B4 SLC39A7 | 8.19e-20 | 736 | 116 | 37 | M27287 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC6A15 SLC15A3 SLC7A6 SLC1A3 SLC4A3 SLC12A5 SLC7A8 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SLC15A1 SLC5A8 SLC12A7 | 9.82e-15 | 108 | 116 | 15 | M823 |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | SLC6A15 SLC15A3 SLC7A6 SLC1A3 SLC4A3 SLC12A5 SLC7A8 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SLC15A1 SLC5A8 SLC12A7 | 1.13e-14 | 109 | 116 | 15 | MM15074 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | SLC44A2 SLC6A15 SLC13A2 RHAG SLC41A2 SLC6A12 SLC22A4 SLC10A6 SLC39A6 SLC13A5 SLC16A7 SLC39A7 | 1.08e-12 | 76 | 116 | 12 | MM15072 |
| Pathway | REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS | SLC44A2 SLC6A15 SLC13A2 RHAG SLC41A2 SLC6A12 SLC22A4 SLC10A6 SLC39A6 SLC13A5 SLC16A7 SLC39A7 | 3.71e-12 | 84 | 116 | 12 | M27334 |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A CHRM3 EDNRB SLC8A1 SLC8A3 P2RX6 CACNA1I CACNA1H CACNA1G ATP2B4 | 2.07e-10 | 178 | 116 | 14 | M2890 |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 4.68e-10 | 23 | 116 | 7 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 9.05e-10 | 25 | 116 | 7 | M47948 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | SLC8A1 SLC8A3 KCNJ12 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 1.07e-07 | 203 | 116 | 12 | M5485 |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 1.21e-06 | 130 | 116 | 9 | M27454 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.70e-05 | 99 | 116 | 7 | M27474 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.86e-05 | 7 | 116 | 3 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 1.86e-05 | 7 | 116 | 3 | MM15081 | |
| Pathway | REACTOME_CARDIAC_CONDUCTION | 2.20e-05 | 103 | 116 | 7 | MM15196 | |
| Pathway | WP_PEPTIDE_GPCRS | 3.46e-05 | 75 | 116 | 6 | M39696 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 4.65e-05 | 79 | 116 | 6 | M17673 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 6.60e-05 | 27 | 116 | 4 | MM15053 | |
| Pathway | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | 7.65e-05 | 28 | 116 | 4 | M924 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 7.93e-05 | 54 | 116 | 5 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 7.93e-05 | 54 | 116 | 5 | MM15202 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 8.67e-05 | 55 | 116 | 5 | M971 | |
| Pathway | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | 1.03e-04 | 57 | 116 | 5 | MM15643 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.13e-04 | 12 | 116 | 3 | M27326 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.15e-04 | 31 | 116 | 4 | M877 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.31e-04 | 32 | 116 | 4 | MM14957 | |
| Pathway | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | 1.48e-04 | 33 | 116 | 4 | M188 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.66e-04 | 63 | 116 | 5 | M11187 | |
| Pathway | REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS | 1.85e-04 | 14 | 116 | 3 | MM15052 | |
| Pathway | WP_GPCRS_PEPTIDE | 2.73e-04 | 70 | 116 | 5 | MM15959 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.94e-04 | 260 | 116 | 9 | M39397 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.83e-04 | 42 | 116 | 4 | M7169 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 4.24e-04 | 165 | 116 | 7 | MM15026 | |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 5.59e-04 | 20 | 116 | 3 | MM15077 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 5.91e-04 | 47 | 116 | 4 | M19708 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 6.46e-04 | 177 | 116 | 7 | M27476 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 6.61e-04 | 5 | 116 | 2 | MM15099 | |
| Pathway | REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS | 6.61e-04 | 5 | 116 | 2 | M27354 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 8.69e-04 | 52 | 116 | 4 | M5785 | |
| Pathway | WP_MAPK_SIGNALING | CACNA1A CACNA1D CACNA1E CACNA1F MAP3K20 CACNA1I CACNA1H CACNA1G | 9.65e-04 | 246 | 116 | 8 | M39597 |
| Pathway | REACTOME_METAL_ION_SLC_TRANSPORTERS | 9.69e-04 | 24 | 116 | 3 | M18795 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 9.85e-04 | 6 | 116 | 2 | M47762 | |
| Pathway | WP_NRF2_PATHWAY | 1.08e-03 | 141 | 116 | 6 | M39454 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY | 1.09e-03 | 25 | 116 | 3 | M47511 | |
| Pathway | WP_PROXIMAL_TUBULE_TRANSPORT | 1.23e-03 | 57 | 116 | 4 | M39812 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.34e-03 | 147 | 116 | 6 | MM15854 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | HTR2A CCR9 FPR1 FPR2 CHRM3 EDNRB TAS2R9 TAS2R5 TAS2R41 C5AR1 HCRTR2 | 1.51e-03 | 463 | 116 | 11 | M507 |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 1.54e-03 | 151 | 116 | 6 | M39329 | |
| Pathway | WP_GPCRS_NONODORANT | 1.59e-03 | 266 | 116 | 8 | MM15843 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | CACNA1A CACNA1D CACNA1E CACNA1F MAP3K20 CACNA1I CACNA1H CACNA1G | 1.63e-03 | 267 | 116 | 8 | M10792 |
| Pathway | REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS | 1.82e-03 | 8 | 116 | 2 | M27370 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 1.82e-03 | 8 | 116 | 2 | MM15106 | |
| Pathway | REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS | 1.82e-03 | 8 | 116 | 2 | MM15110 | |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | 1.83e-03 | 272 | 116 | 8 | M13380 | |
| Pathway | REACTOME_TIGHT_JUNCTION_INTERACTIONS | 1.87e-03 | 30 | 116 | 3 | M17967 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.97e-03 | 108 | 116 | 5 | M17034 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.26e-03 | 32 | 116 | 3 | M27455 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 2.33e-03 | 9 | 116 | 2 | M27688 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS | 2.33e-03 | 9 | 116 | 2 | MM15421 | |
| Pathway | REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY | 2.89e-03 | 10 | 116 | 2 | M27361 | |
| Pathway | WP_DRAVET_SYNDROME_SCN1AA1783V_POINT_MUTATION_MODEL | 3.06e-03 | 73 | 116 | 4 | MM16641 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 3.33e-03 | 176 | 116 | 6 | MM15718 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY | 3.44e-03 | 37 | 116 | 3 | M47769 | |
| Pathway | REACTOME_SODIUM_CALCIUM_EXCHANGERS | 3.52e-03 | 11 | 116 | 2 | M27336 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.52e-03 | 11 | 116 | 2 | MM14498 | |
| Pathway | REACTOME_ZINC_TRANSPORTERS | 3.52e-03 | 11 | 116 | 2 | MM15101 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 3.52e-03 | 11 | 116 | 2 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 3.52e-03 | 11 | 116 | 2 | M47958 | |
| Pathway | REACTOME_PLATELET_HOMEOSTASIS | 3.54e-03 | 76 | 116 | 4 | MM15051 | |
| Pathway | WP_SLEEP_REGULATION | 3.71e-03 | 38 | 116 | 3 | M39504 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 3.89e-03 | 78 | 116 | 4 | M1921 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 4.00e-03 | 39 | 116 | 3 | M793 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | 4.03e-03 | 183 | 116 | 6 | M997 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 4.36e-03 | 186 | 116 | 6 | MM15994 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | CACNA1A CACNA1D CACNA1E CACNA1F SLC8A1 SLC8A3 CACNA1I CACNA1G ATP2B4 | 6.70e-14 | 38 | 152 | 9 | 30786075 |
| Pubmed | 1.75e-13 | 8 | 152 | 6 | 28330839 | ||
| Pubmed | 5.24e-13 | 9 | 152 | 6 | 16382099 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | CACNA1A CACNA1D CACNA1E CACNA1F SLC8A1 P2RX6 SCN4A SCN5A SCN9A CACNA1H CACNA1G | 2.98e-11 | 139 | 152 | 11 | 16985003 |
| Pubmed | 3.11e-11 | 7 | 152 | 5 | 12900400 | ||
| Pubmed | CACNA1A CACNA1E HTR2A PCDHA7 SLC1A3 SLC4A3 SLC12A5 SLC7A8 SLC8A1 SLC9A1 SCN9A SLC39A6 ATP1A1 ATP1A3 SLC16A7 | 3.57e-10 | 405 | 152 | 15 | 38187761 | |
| Pubmed | 1.75e-09 | 5 | 152 | 4 | 12060068 | ||
| Pubmed | Appearance of new tetraspanin genes during vertebrate evolution. | 2.19e-08 | 20 | 152 | 5 | 18291621 | |
| Pubmed | 2.42e-08 | 8 | 152 | 4 | 34478646 | ||
| Pubmed | ATP7A ATP7B SLC6A15 SLC1A3 SEMA4C SLC35F5 SLC9A1 AAAS WDR11 UCHL1 STOML1 SLC35A2 TMEM209 SLC39A6 ATP1A1 STX7 SLC12A7 ATP2B4 SLC39A7 | 4.03e-08 | 952 | 152 | 19 | 38569033 | |
| Pubmed | 4.34e-08 | 9 | 152 | 4 | 19323993 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 8.18e-08 | 3 | 152 | 3 | 23488970 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 24966091 | ||
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 8.18e-08 | 3 | 152 | 3 | 11230107 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 8.18e-08 | 3 | 152 | 3 | 28972185 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 11897840 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 8.18e-08 | 3 | 152 | 3 | 18591418 | |
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 28846697 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 32555258 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 11927664 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 20038812 | ||
| Pubmed | 8.18e-08 | 3 | 152 | 3 | 23164356 | ||
| Pubmed | 1.63e-07 | 29 | 152 | 5 | 15071553 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | SLC6A15 SLC1A3 SEMA4C SLC9A1 SLC15A1 EXD2 SLC22A4 SLC35A2 ATP1A1 STX7 SLC12A7 ATP2B4 VPS13B GPRC5B | 2.32e-07 | 569 | 152 | 14 | 30639242 |
| Pubmed | CACNA1D CACNA1E SLC13A2 SLC5A1 SLC6A12 SLC8A1 SLC15A1 GPRC5B | 2.39e-07 | 143 | 152 | 8 | 20424473 | |
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 31800012 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 3.26e-07 | 4 | 152 | 3 | 28165634 | |
| Pubmed | 3.26e-07 | 4 | 152 | 3 | 1612600 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 3.26e-07 | 4 | 152 | 3 | 21788606 | |
| Pubmed | ATP7A ATP7B SLC6A15 SNX19 SEMA4C AAAS EXD2 SLC35A2 TMEM209 C9orf72 STX7 SLC12A7 VPS13B | 3.75e-07 | 504 | 152 | 13 | 34432599 | |
| Pubmed | 4.22e-07 | 105 | 152 | 7 | 30280653 | ||
| Pubmed | 4.61e-07 | 15 | 152 | 4 | 20188150 | ||
| Pubmed | 4.61e-07 | 15 | 152 | 4 | 24453333 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 7.98e-07 | 17 | 152 | 4 | 27725084 | |
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 11296258 | ||
| Pubmed | 8.13e-07 | 5 | 152 | 3 | 15451373 | ||
| Pubmed | Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. | 9.85e-07 | 41 | 152 | 5 | 23676500 | |
| Pubmed | SLC6A15 SLC1A3 SEMA4C SLC9A1 AAAS SLC35A2 TMEM209 SLC39A6 ATP1A1 TMEM109 STX7 ATP2B4 | 1.11e-06 | 467 | 152 | 12 | 30194290 | |
| Pubmed | GATA6 is a regulator of sinus node development and heart rhythm. | 1.61e-06 | 20 | 152 | 4 | 33443158 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.62e-06 | 6 | 152 | 3 | 12827191 | |
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 2.41e-06 | 22 | 152 | 4 | 18391953 | |
| Pubmed | 4.51e-06 | 8 | 152 | 3 | 19683723 | ||
| Pubmed | CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans. | 4.51e-06 | 8 | 152 | 3 | 10741407 | |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 4.51e-06 | 8 | 152 | 3 | 21613606 | |
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 4.51e-06 | 8 | 152 | 3 | 12761855 | |
| Pubmed | 6.74e-06 | 9 | 152 | 3 | 15253893 | ||
| Pubmed | 6.74e-06 | 9 | 152 | 3 | 16382098 | ||
| Pubmed | 6.74e-06 | 9 | 152 | 3 | 15746173 | ||
| Pubmed | Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. | 7.65e-06 | 29 | 152 | 4 | 23708969 | |
| Pubmed | AHCTF1 FASN WDR11 EXD2 SLC35A2 TMEM209 PRAF2 C9orf72 TMEM109 SLC12A7 VPS13B SLC39A7 | 8.22e-06 | 568 | 152 | 12 | 37774976 | |
| Pubmed | Claudin association with CD81 defines hepatitis C virus entry. | 9.60e-06 | 10 | 152 | 3 | 20375010 | |
| Pubmed | 9.60e-06 | 10 | 152 | 3 | 24778262 | ||
| Pubmed | 9.60e-06 | 10 | 152 | 3 | 23091066 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.01e-05 | 31 | 152 | 4 | 18195088 | |
| Pubmed | Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. | 1.01e-05 | 31 | 152 | 4 | 17473172 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | CCR9 SLC44A2 CHRM3 SLC4A3 SLC22A17 SLC12A5 CD82 TSPAN4 CACNA1H STARD3NL ATP1A1 GPRC5B SLC35B1 | 1.29e-05 | 697 | 152 | 13 | 28298427 |
| Pubmed | 1.32e-05 | 11 | 152 | 3 | 18809727 | ||
| Pubmed | Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins. | SLC44A2 SLC12A8 SNX19 SLC22A17 SLC35F5 SLC35A2 SCN9A ATP1A1 PRAF2 TMEM109 ATP2B4 | 1.34e-05 | 499 | 152 | 11 | 22810586 |
| Pubmed | A high-density association screen of 155 ion transport genes for involvement with common migraine. | 1.75e-05 | 12 | 152 | 3 | 18676988 | |
| Pubmed | 1.75e-05 | 12 | 152 | 3 | 10229664 | ||
| Pubmed | 1.75e-05 | 12 | 152 | 3 | 12736707 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ATP7B SLC6A15 SLC46A1 SLC7A6 SEMA4C SLC35F5 SLC9A1 UCHL1 ALG14 SLC35A2 MFSD8 STARD3NL PRAF2 STX7 SLC12A7 ATP2B4 | 1.78e-05 | 1061 | 152 | 16 | 33845483 |
| Pubmed | Systematic identification of pathological lamin A interactors. | SGMS2 GPR25 ABCA9 RHAG SLC41A2 C20orf141 TMEM218 TMEM109 STX7 | 1.89e-05 | 337 | 152 | 9 | 24623722 |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 29394468 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 8082762 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 18079277 | ||
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 1.90e-05 | 2 | 152 | 2 | 12808460 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 14988077 | ||
| Pubmed | Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus. | 1.90e-05 | 2 | 152 | 2 | 17804490 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 19645496 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 24978055 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 21622683 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 21115196 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 10477558 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 25071191 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 35217703 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 17692291 | ||
| Pubmed | The organization of the human gene NCX1 encoding the sodium-calcium exchanger. | 1.90e-05 | 2 | 152 | 2 | 8921376 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 33920954 | ||
| Pubmed | Mechanisms of charge transfer in human copper ATPases ATP7A and ATP7B. | 1.90e-05 | 2 | 152 | 2 | 28164426 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 23147350 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 20685979 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 36786913 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 26071379 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 22270364 | ||
| Pubmed | Biochemical basis of regulation of human copper-transporting ATPases. | 1.90e-05 | 2 | 152 | 2 | 17562324 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 9823011 | ||
| Pubmed | Expression of KAI1/CD82 and MRP-1/CD9 in transitional cell carcinoma of bladder. | 1.90e-05 | 2 | 152 | 2 | 17393117 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 26627919 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 17717039 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 23583405 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 1.90e-05 | 2 | 152 | 2 | 25966695 | |
| Pubmed | A Critical Role of Formyl Peptide Receptors in Host Defense against Escherichia coli. | 1.90e-05 | 2 | 152 | 2 | 32221037 | |
| Pubmed | All human Na(+)-K(+)-ATPase alpha-subunit isoforms have a similar affinity for cardiac glycosides. | 1.90e-05 | 2 | 152 | 2 | 11546672 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 20045993 | ||
| Pubmed | Genetic determinants of gut microbiota composition and bile acid profiles in mice. | 1.90e-05 | 2 | 152 | 2 | 31465442 | |
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 30540534 | ||
| Pubmed | 1.90e-05 | 2 | 152 | 2 | 18996841 | ||
| Interaction | NALCN interactions | 3.30e-08 | 14 | 144 | 5 | int:NALCN | |
| Interaction | CX3CL1 interactions | 4.07e-08 | 71 | 144 | 8 | int:CX3CL1 | |
| Interaction | SLC6A8 interactions | 9.18e-08 | 145 | 144 | 10 | int:SLC6A8 | |
| Interaction | SSTR3 interactions | CACNA1A CACNA1E HTR2A PCDHA7 SLC1A3 SLC4A3 SLC12A5 SLC7A8 SLC8A1 SLC9A1 SCN9A SLC39A6 ATP1A1 ATP1A3 SLC16A7 | 1.49e-07 | 393 | 144 | 15 | int:SSTR3 |
| Interaction | GPR89A interactions | 2.01e-07 | 120 | 144 | 9 | int:GPR89A | |
| Interaction | GJA8 interactions | MFSD11 SLC13A2 SLC16A12 SLC8A3 GPR61 SLC13A5 PRAF2 STX7 SLC39A7 GPRC5B | 2.31e-07 | 160 | 144 | 10 | int:GJA8 |
| Interaction | SLC25A46 interactions | AHCTF1 SLC7A8 AAAS SLC15A1 EXD2 SLC22A4 SLC10A6 TMEM209 C5AR1 SLC5A8 C9orf72 HCRTR2 | 5.03e-07 | 267 | 144 | 12 | int:SLC25A46 |
| Interaction | CACNA1D interactions | 6.62e-07 | 24 | 144 | 5 | int:CACNA1D | |
| Interaction | GJD3 interactions | ATP7A ATP7B SLC6A15 SNX19 SEMA4C SLC9A1 AAAS SLC35A2 TMEM209 SLC39A6 ATP1A1 PRAF2 TMEM109 SLC12A7 VPS13B | 9.31e-07 | 454 | 144 | 15 | int:GJD3 |
| Interaction | ARF6 interactions | FLT4 HTR2A SLC6A15 SLC7A6 SLC1A3 CHRM3 SEMA4C SLC9A1 WDR11 MAP4K5 TMEM209 SLC39A6 ATP1A1 PRAF2 STX7 SLC12A7 ATP2B4 | 9.73e-07 | 584 | 144 | 17 | int:ARF6 |
| Interaction | ATP13A3 interactions | 1.06e-06 | 146 | 144 | 9 | int:ATP13A3 | |
| Interaction | NRAS interactions | ATP7A SLC6A15 LCP1 SLC1A3 SEMA4C SLC9A1 AAAS CD9 SLC35A2 TMEM209 SLC39A6 ATP1A1 C9orf72 TMEM109 STX7 SLC12A7 ATP2B4 VPS13B | 2.61e-06 | 699 | 144 | 18 | int:NRAS |
| Interaction | CDS1 interactions | 2.90e-06 | 56 | 144 | 6 | int:CDS1 | |
| Interaction | SCN11A interactions | 3.21e-06 | 15 | 144 | 4 | int:SCN11A | |
| Interaction | GJA1 interactions | ILDR2 ATP7A SLC6A15 SLC15A3 SEMA4C TSPAN17 TSPAN10 MAP4K5 SCN4A TMEM209 SLC39A6 ATP1A1 STX7 SLC12A7 ATP2B4 VPS13B | 4.41e-06 | 583 | 144 | 16 | int:GJA1 |
| Interaction | RHOC interactions | ATP7A SLC6A15 SLC9A1 AAAS WDR11 EXD2 SLC22A4 TMEM209 SLC39A6 ATP1A1 TMEM109 STX7 SLC12A7 SLC16A7 VPS13B SLC39A7 | 4.50e-06 | 584 | 144 | 16 | int:RHOC |
| Interaction | ELOVL2 interactions | 4.82e-06 | 61 | 144 | 6 | int:ELOVL2 | |
| Interaction | RAB5C interactions | ATP7A SLC6A15 SNX19 SEMA4C FASN WDR11 EXD2 TMEM209 SLC39A6 ATP1A1 PRAF2 C9orf72 TMEM109 STX7 SLC12A7 SLC39A7 | 6.33e-06 | 600 | 144 | 16 | int:RAB5C |
| Interaction | RAC2 interactions | SLC6A15 SLC1A3 SLC9A1 AAAS WDR11 EXD2 SLC22A4 KCNJ12 TMEM209 SLC39A6 ATP1A1 TMEM109 STX7 SLC12A7 SLC16A7 VPS13B SLC39A7 | 6.66e-06 | 674 | 144 | 17 | int:RAC2 |
| Interaction | LMBRD2 interactions | 7.00e-06 | 65 | 144 | 6 | int:LMBRD2 | |
| Interaction | AGPAT2 interactions | 8.36e-06 | 67 | 144 | 6 | int:AGPAT2 | |
| Interaction | AGPAT4 interactions | 1.17e-05 | 71 | 144 | 6 | int:AGPAT4 | |
| Interaction | SCN9A interactions | 1.36e-05 | 21 | 144 | 4 | int:SCN9A | |
| Interaction | RAB2A interactions | TMEM67 ATP7A SLC6A15 SLC7A6 SLC1A3 FASN SLC9A1 SLC35A2 SLC39A6 MFSD8 ATP1A1 TMEM109 STX7 SLC12A7 SLC39A7 | 1.38e-05 | 567 | 144 | 15 | int:RAB2A |
| Interaction | C5AR1 interactions | 1.52e-05 | 154 | 144 | 8 | int:C5AR1 | |
| Interaction | RHOD interactions | SLC6A15 SLC7A6 SLC9A1 AAAS WDR11 EXD2 SLC22A4 TMEM209 SLC39A6 ATP1A1 TMEM109 STX7 SLC12A7 SLC16A7 SLC39A7 | 1.53e-05 | 572 | 144 | 15 | int:RHOD |
| Interaction | LAMTOR1 interactions | ATP7A ATP7B SLC6A15 SLC15A3 SLC1A3 SEMA4C WDR11 MAP4K5 SLC39A6 MFSD8 ATP1A1 PRAF2 C9orf72 STX7 SLC12A7 ATP2B4 VPS13B | 1.62e-05 | 722 | 144 | 17 | int:LAMTOR1 |
| Interaction | RND2 interactions | SLC6A15 SLC9A1 AAAS WDR11 EXD2 SLC22A4 TMEM209 SLC39A6 ATP1A1 STX7 SLC12A7 VPS13B SLC39A7 | 1.69e-05 | 440 | 144 | 13 | int:RND2 |
| Interaction | CD63 interactions | 1.79e-05 | 114 | 144 | 7 | int:CD63 | |
| Interaction | RAC1 interactions | CYBB ATP7A SLC6A15 SLC7A6 SLC1A3 FASN SLC9A1 AAAS WDR11 MAP4K5 SLC22A4 KCNJ12 TMEM209 SLC39A6 ATP1A1 ATP1A3 TMEM109 STX7 SLC12A7 SLC16A7 SLC39A7 | 2.20e-05 | 1063 | 144 | 21 | int:RAC1 |
| Interaction | HSD17B11 interactions | TMEM67 SLC6A15 SNX19 FASN SLC9A1 AAAS TMEM209 ATP1A1 PRAF2 C9orf72 TMEM109 STX7 | 2.43e-05 | 390 | 144 | 12 | int:HSD17B11 |
| Interaction | RHOF interactions | ATP7A AHCTF1 SLC6A15 SLC7A6 SLC1A3 SLC9A1 AAAS WDR11 SLC22A4 TMEM209 SLC39A6 ATP1A1 SLC12A7 SLC16A7 VPS13B SLC39A7 | 2.61e-05 | 673 | 144 | 16 | int:RHOF |
| Interaction | TMEM17 interactions | ATP7A SLC6A15 SLC1A3 SEMA4C SLC9A1 WDR11 TMEM209 SLC39A6 ATP1A1 STX7 SLC12A7 ATP2B4 | 3.43e-05 | 404 | 144 | 12 | int:TMEM17 |
| Interaction | TMEM161B interactions | 4.48e-05 | 28 | 144 | 4 | int:TMEM161B | |
| Interaction | ATP9A interactions | 4.56e-05 | 90 | 144 | 6 | int:ATP9A | |
| Interaction | LAMP3 interactions | ATP7A ATP7B AHCTF1 SLC6A15 SLC1A3 SLC9A1 AAAS SLC39A6 MFSD8 ATP1A1 PRAF2 TMEM109 STX7 | 4.74e-05 | 486 | 144 | 13 | int:LAMP3 |
| Interaction | TVP23C interactions | 4.95e-05 | 56 | 144 | 5 | int:TVP23C | |
| Interaction | OR4D1 interactions | 5.07e-05 | 2 | 144 | 2 | int:OR4D1 | |
| Interaction | SCN1A interactions | 5.17e-05 | 29 | 144 | 4 | int:SCN1A | |
| Interaction | ATP12A interactions | 5.22e-05 | 183 | 144 | 8 | int:ATP12A | |
| Interaction | SCN10A interactions | 5.65e-05 | 11 | 144 | 3 | int:SCN10A | |
| Interaction | YIPF3 interactions | 5.85e-05 | 186 | 144 | 8 | int:YIPF3 | |
| Interaction | ELOVL5 interactions | SLC6A15 SEMA4C TSPAN10 SLC35A2 TMEM209 SLC39A6 ATP1A1 PRAF2 STX7 SLC12A7 VPS13B | 6.30e-05 | 364 | 144 | 11 | int:ELOVL5 |
| Interaction | OCLN interactions | ILDR2 ATP7A AIMP2 FPR1 SLC6A15 SEMA4C MAP4K5 SLC22A4 SLC39A6 ATP1A1 STX7 SLC12A7 ATP2B4 | 6.33e-05 | 500 | 144 | 13 | int:OCLN |
| Interaction | RAB35 interactions | ATP7A SLC6A15 SLC1A3 SEMA4C SLC9A1 MAP4K5 EXD2 TMEM209 SLC39A6 ATP1A1 C9orf72 STX7 SLC12A7 ATP2B4 | 6.40e-05 | 573 | 144 | 14 | int:RAB35 |
| Interaction | FITM2 interactions | ATP7A FPR2 SLC7A8 DAP3 FASN TSPAN10 SLC22A4 SCN4A SLC39A6 C5AR1 | 8.01e-05 | 310 | 144 | 10 | int:FITM2 |
| Interaction | SFXN5 interactions | 8.10e-05 | 62 | 144 | 5 | int:SFXN5 | |
| Interaction | RHOG interactions | SLC6A15 SLC7A6 DAP3 SLC9A1 AAAS WDR11 EXD2 SLC22A4 KCNJ12 TMEM209 SLC39A6 ATP1A1 C9orf72 TMEM109 STX7 SLC12A7 SLC16A7 VPS13B | 8.83e-05 | 910 | 144 | 18 | int:RHOG |
| Interaction | RAB9A interactions | ATP7B SLC6A15 SEMA4C WDR11 TSPAN10 TMEM209 SLC39A6 MFSD8 ATP1A1 C9orf72 STX7 SLC12A7 ATP2B4 VPS13B | 9.54e-05 | 595 | 144 | 14 | int:RAB9A |
| Interaction | DERL1 interactions | AHCTF1 FPR2 SNX19 SLC7A8 AAAS UCHL1 SLC10A6 TMEM209 ATP1A1 PRAF2 TMEM109 ATP2B4 | 1.03e-04 | 453 | 144 | 12 | int:DERL1 |
| Interaction | RHOB interactions | ATP7A SLC6A15 SLC7A6 SLC1A3 SEMA4C SLC9A1 AAAS MAP4K5 SLC22A4 TMEM209 SLC39A6 ATP1A1 PRAF2 STX7 SLC12A7 SLC16A7 ATP2B4 | 1.07e-04 | 840 | 144 | 17 | int:RHOB |
| Interaction | DIRAS3 interactions | ILDR2 ATP7A SLC6A15 SEMA4C SLC9A1 MAP4K5 SLC39A6 ATP1A1 SLC12A7 | 1.14e-04 | 262 | 144 | 9 | int:DIRAS3 |
| Interaction | CD79A interactions | TMEM67 SLC16A12 SLC41A2 SLC6A12 SLC13A5 TMEM218 PRAF2 SLC12A7 SLC35B1 | 1.14e-04 | 262 | 144 | 9 | int:CD79A |
| Interaction | SLC7A2 interactions | 1.33e-04 | 109 | 144 | 6 | int:SLC7A2 | |
| Interaction | LPAR1 interactions | 1.36e-04 | 210 | 144 | 8 | int:LPAR1 | |
| Interaction | CACNA1B interactions | 1.37e-04 | 37 | 144 | 4 | int:CACNA1B | |
| Interaction | RAC3 interactions | ATP7A SLC6A15 SLC9A1 AAAS WDR11 EXD2 SLC22A4 KCNJ12 TMEM209 SLC39A6 ATP1A1 STX7 SLC12A7 SLC16A7 | 1.44e-04 | 619 | 144 | 14 | int:RAC3 |
| Interaction | TSPAN15 interactions | ZDHHC17 SLC7A6 SNX19 SLC22A4 SCN4A TSPAN6 MFSD8 ATP1A3 HCRTR2 | 1.69e-04 | 276 | 144 | 9 | int:TSPAN15 |
| Interaction | HCRTR2 interactions | 1.69e-04 | 39 | 144 | 4 | int:HCRTR2 | |
| Interaction | ZFP2 interactions | 1.87e-04 | 16 | 144 | 3 | int:ZFP2 | |
| Interaction | PRRT2 interactions | 1.87e-04 | 220 | 144 | 8 | int:PRRT2 | |
| Interaction | MGARP interactions | 1.99e-04 | 222 | 144 | 8 | int:MGARP | |
| Interaction | RETREG3 interactions | 1.99e-04 | 222 | 144 | 8 | int:RETREG3 | |
| Interaction | PTRH2 interactions | 2.06e-04 | 223 | 144 | 8 | int:PTRH2 | |
| Interaction | TACR3 interactions | 2.14e-04 | 76 | 144 | 5 | int:TACR3 | |
| Interaction | CAV1 interactions | SLC6A15 SLC1A3 CHRM3 EDNRB FASN MAP4K5 SLC22A4 SLC39A6 SLC5A8 ATP1A1 PRAF2 STX7 SLC12A7 ATP2B4 VPS13B | 2.16e-04 | 724 | 144 | 15 | int:CAV1 |
| Interaction | HRAS interactions | ATP7A LCP1 SLC1A3 SEMA4C SLC9A1 AAAS CD9 SLC22A4 SLC35A2 SLC39A6 ATP1A1 C9orf72 STX7 SLC12A7 ATP2B4 | 2.19e-04 | 725 | 144 | 15 | int:HRAS |
| Interaction | SLC22A9 interactions | 2.24e-04 | 120 | 144 | 6 | int:SLC22A9 | |
| Interaction | WBP1 interactions | 2.27e-04 | 42 | 144 | 4 | int:WBP1 | |
| Interaction | TMT1A interactions | SLC6A15 SNX19 SEMA4C SLC9A1 TSPAN17 AAAS TMEM209 ATP1A1 TMEM109 VPS13B | 2.64e-04 | 359 | 144 | 10 | int:TMT1A |
| Interaction | SEC62 interactions | SLC6A15 SNX19 SEMA4C SLC9A1 AAAS SCN4A TMEM209 SLC39A6 ATP1A1 ATP1A3 PRAF2 TMEM109 | 2.85e-04 | 506 | 144 | 12 | int:SEC62 |
| Interaction | RHOH interactions | SLC6A15 SLC9A1 AAAS WDR11 SLC22A4 TMEM209 SLC39A6 ATP1A1 SLC12A7 SLC16A7 VPS13B SLC39A7 | 3.17e-04 | 512 | 144 | 12 | int:RHOH |
| Interaction | BTAF1 interactions | 3.18e-04 | 128 | 144 | 6 | int:BTAF1 | |
| Interaction | DLG2 interactions | 3.22e-04 | 83 | 144 | 5 | int:DLG2 | |
| Interaction | DLG1 interactions | 3.37e-04 | 240 | 144 | 8 | int:DLG1 | |
| Interaction | TCTN2 interactions | CACNA1A TMEM67 SNX19 SLC9A1 AAAS TMEM209 PRAF2 TMEM109 SLC39A7 | 3.45e-04 | 304 | 144 | 9 | int:TCTN2 |
| Interaction | RHOA interactions | ATP7A MFSD11 SLC6A15 SLC7A6 SLC9A1 AAAS WDR11 EXD2 SLC22A4 KCNJ12 TMEM209 SLC39A6 ATP1A1 C9orf72 TMEM109 STX7 SLC12A7 SLC16A7 VPS13B SLC39A7 | 3.45e-04 | 1199 | 144 | 20 | int:RHOA |
| Interaction | SCN5A interactions | 3.51e-04 | 47 | 144 | 4 | int:SCN5A | |
| Interaction | RXYLT1 interactions | 3.73e-04 | 20 | 144 | 3 | int:RXYLT1 | |
| Interaction | SLC12A7 interactions | 3.75e-04 | 132 | 144 | 6 | int:SLC12A7 | |
| Interaction | SEC61B interactions | SLC6A15 SLC15A3 SNX19 SEMA4C SLC35A3 SLC9A1 AAAS AGER TMEM209 ATP1A1 PRAF2 C9orf72 TMEM109 ATP2B4 SLC39A7 | 3.77e-04 | 763 | 144 | 15 | int:SEC61B |
| Interaction | MFSD5 interactions | 3.80e-04 | 86 | 144 | 5 | int:MFSD5 | |
| Interaction | ZFPL1 interactions | SGMS2 SLC19A3 SLC6A15 SLC9A1 EXD2 SLC10A6 SLC39A6 ATP1A1 STX7 SLC12A7 VPS13B | 3.83e-04 | 448 | 144 | 11 | int:ZFPL1 |
| Interaction | ATP1A3 interactions | 4.09e-04 | 247 | 144 | 8 | int:ATP1A3 | |
| Interaction | ARL10 interactions | 4.26e-04 | 189 | 144 | 7 | int:ARL10 | |
| Interaction | STUM interactions | 4.32e-04 | 21 | 144 | 3 | int:STUM | |
| Interaction | LAMP2 interactions | ATP7A ATP7B SLC6A15 WDR11 TSPAN10 UCHL1 TMEM209 SLC39A6 MFSD8 ATP1A1 PRAF2 C9orf72 STX7 | 4.36e-04 | 609 | 144 | 13 | int:LAMP2 |
| Interaction | RAB4A interactions | ATP7A ATP7B AIMP2 SLC6A15 SEMA4C WDR11 EXD2 SLC39A6 STX7 SLC12A7 VPS13B | 4.53e-04 | 457 | 144 | 11 | int:RAB4A |
| Interaction | HSD3B7 interactions | SLC6A15 SNX19 SEMA4C SLC9A1 AAAS SLC35A2 TMEM209 ATP1A1 PRAF2 TMEM109 | 4.67e-04 | 386 | 144 | 10 | int:HSD3B7 |
| Interaction | SLC22A4 interactions | 4.68e-04 | 192 | 144 | 7 | int:SLC22A4 | |
| Interaction | GJB6 interactions | 4.98e-04 | 22 | 144 | 3 | int:GJB6 | |
| Interaction | AGER interactions | 4.98e-04 | 22 | 144 | 3 | int:AGER | |
| Interaction | GPR61 interactions | 4.98e-04 | 22 | 144 | 3 | int:GPR61 | |
| Interaction | TNFSF8 interactions | 5.33e-04 | 141 | 144 | 6 | int:TNFSF8 | |
| Interaction | EMD interactions | FLT4 AHCTF1 SLC15A3 SNX19 FASN SLC9A1 AAAS KCNJ12 TMEM209 KCNJ18 ATP1A1 C9orf72 TMEM109 STX7 VPS13B | 5.34e-04 | 789 | 144 | 15 | int:EMD |
| Interaction | CLEC2D interactions | 5.45e-04 | 197 | 144 | 7 | int:CLEC2D | |
| Interaction | PTPN1 interactions | FLT4 AHCTF1 SLC15A3 SNX19 FASN AAAS EXD2 SCN4A TMEM209 C5AR1 ATP1A1 C9orf72 STX7 | 5.55e-04 | 625 | 144 | 13 | int:PTPN1 |
| Interaction | SPRING1 interactions | 5.59e-04 | 259 | 144 | 8 | int:SPRING1 | |
| Interaction | FXYD3 interactions | 5.72e-04 | 94 | 144 | 5 | int:FXYD3 | |
| Interaction | RNF149 interactions | ATP7A ATP7B SLC6A15 SEMA4C FASN TSPAN17 AAAS TMEM209 SLC39A6 TMEM109 STX7 ATP2B4 | 5.90e-04 | 549 | 144 | 12 | int:RNF149 |
| GeneFamily | Solute carriers | SLC25A20 SLC19A3 SLC44A2 SLC6A15 SLC12A8 SLC46A1 SLC15A3 SLC7A6 SLC13A2 SLC1A3 SLC4A3 SLC22A17 SLC16A12 RHAG SLC5A1 SLC12A5 SLC35F5 SLC7A8 SLC41A2 SLC6A12 SLC8A1 SLC35A3 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 SLC22A4 SLC35A2 SLC10A6 SLC39A6 SLC13A5 SLC5A8 SLC12A7 SLC16A7 SLC39A7 SLC35B1 | 1.21e-31 | 395 | 126 | 37 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 3.98e-10 | 26 | 126 | 7 | 253 | |
| GeneFamily | CD molecules|Tetraspanins | 2.48e-09 | 33 | 126 | 7 | 768 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.69e-05 | 9 | 126 | 3 | 1203 | |
| GeneFamily | ATPase copper transporting | 4.82e-05 | 2 | 126 | 2 | 1212 | |
| GeneFamily | Formyl peptide receptors | 1.44e-04 | 3 | 126 | 2 | 198 | |
| GeneFamily | Claudins | 5.29e-04 | 23 | 126 | 3 | 488 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 9.89e-04 | 7 | 126 | 2 | 1208 | |
| GeneFamily | G protein-coupled receptors, Class C orphans | 9.89e-04 | 7 | 126 | 2 | 285 | |
| GeneFamily | Olfactory receptors, family 4 | 2.10e-03 | 129 | 126 | 5 | 151 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 2.15e-03 | 78 | 126 | 4 | 262 | |
| GeneFamily | Taste 2 receptors | 2.51e-03 | 39 | 126 | 3 | 1162 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 5.42e-03 | 16 | 126 | 2 | 276 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SGMS2 TSPAN11 MFSD11 SLC44A2 SLC46A1 SLC7A6 CLDN9 SEMA4C SLC9A1 CD9 SLC35A2 TSPAN6 TSPAN4 SLC39A6 ATP1A1 TMEM109 SLC39A7 GPRC5B | 6.87e-08 | 681 | 149 | 18 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | SGMS2 TSPAN11 MFSD11 SLC44A2 SLC46A1 SLC7A6 CLDN9 SEMA4C SLC9A1 CD9 SLC35A2 TSPAN6 TSPAN4 SLC39A6 ATP1A1 TMEM109 SLC39A7 GPRC5B | 1.10e-07 | 703 | 149 | 18 | MM1055 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_UP | CYBB CACNA1A CACNA1D CMKLR2 HTR2A ATP7B SLC13A2 SLC4A3 SLC5A1 SLC12A5 SLC6A12 SLC8A1 SLC8A3 SLC10A2 SLC15A1 UCHL1 AGER GYS2 SCN9A CACNA1H ATP1A3 STX7 | 3.56e-06 | 1281 | 149 | 22 | M1884 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HSERT | CACNA1A CACNA1E PCDHA7 SLC6A15 SLC4A3 SLC22A17 SLC12A5 NRXN2 UCHL1 SCN9A CACNA1G ATP1A3 | 1.08e-05 | 450 | 149 | 12 | M39072 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | MFSD11 AHCTF1 SLC44A2 SLC7A6 CLDN9 SEMA4C CD9 SLC35A2 ATP1A1 TMEM109 SLC39A7 GPRC5B | 1.26e-05 | 457 | 149 | 12 | M1613 |
| Coexpression | MILI_PSEUDOPODIA_CHEMOTAXIS_DN | MFSD11 AHCTF1 SLC44A2 SLC7A6 CLDN9 SEMA4C CD9 SLC35A2 ATP1A1 TMEM109 SLC39A7 GPRC5B | 1.66e-05 | 470 | 149 | 12 | MM1053 |
| Coexpression | GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP | 1.85e-05 | 198 | 149 | 8 | M9778 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 4.94e-05 | 167 | 149 | 7 | M1430 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | CYBB CACNA1D CACNA1E CCR9 SLC44A2 SPNS3 SLC15A3 SEMA4C SLC41A2 MAP4K5 STOML1 ATP1A3 STX7 ATP2B4 | 7.89e-07 | 412 | 143 | 14 | GSM605843_500 |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3 | CYBB CACNA1D CACNA1E CCR9 SLC44A2 SPNS3 SLC15A3 SEMA4C SLC41A2 MAP4K5 STOML1 ATP1A3 STX7 ATP2B4 | 8.60e-07 | 415 | 143 | 14 | GSM854299_500 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | CYBB SGMS2 MFSD11 SLC15A3 ABCA9 EDNRB SLC35F5 SLC7A8 SLC41A2 TSPAN4 C5AR1 ATP1A3 SLC16A7 GPRC5B | 1.58e-06 | 437 | 143 | 14 | GSM605865_500 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | CYBB MFSD11 SLC15A3 ABCA9 EDNRB SLC35F5 SLC7A8 SLC41A2 CD9 TSPAN4 C5AR1 ATP1A3 SLC16A7 GPRC5B | 1.76e-06 | 441 | 143 | 14 | GSM605862_500 |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | CYBB CACNA1E CCR9 SLC44A2 SPNS3 SLC15A3 SEMA4C SLC41A2 MAP4K5 STOML1 ATP1A3 STX7 ATP2B4 | 4.14e-06 | 409 | 143 | 13 | GSM605840_500 |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | CYBB CACNA1D CACNA1E CCR9 SLC44A2 SPNS3 SEMA4C SLC41A2 MAP4K5 STOML1 ATP1A3 STX7 ATP2B4 | 4.25e-06 | 410 | 143 | 13 | GSM854297_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II-.Bl, CD115+ B220- CD43- Ly6C- MHCII-, Blood, avg-3 | CYBB ATP7A FPR1 SLC15A3 ABCA9 CALHM2 ARHGEF10L SLC8A1 CD9 C5AR1 ATP1A3 SLC16A7 | 1.84e-05 | 402 | 143 | 12 | GSM605883_500 |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | CYBB MFSD11 SLC15A3 ABCA9 EDNRB SLC35F5 SLC7A8 SLC41A2 C5AR1 ATP1A3 SLC16A7 GPRC5B | 3.80e-05 | 433 | 143 | 12 | GSM605856_500 |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-IIint.Bl, CD115+ B220- CD43- Ly6C- MHCIIint, Blood, avg-5 | CYBB ATP7A FPR1 SLC15A3 ABCA9 ARHGEF10L SLC8A1 CD9 C5AR1 ATP1A3 SLC16A7 | 8.65e-05 | 400 | 143 | 11 | GSM605886_500 |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | CYBB CMBL FPR1 SLC15A3 SLC1A3 ABCA9 SLC7A8 SLC8A1 TSPAN4 C9orf72 SLC16A7 | 9.24e-05 | 403 | 143 | 11 | GSM605853_500 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | CMBL SGMS2 CWH43 MAP3K20 SLC6A15 SLC16A12 EDNRB SLC5A1 SLC7A8 SLC8A1 SLC35A3 SLC12A3 GYS2 SLC5A8 ATP1A1 SLC16A7 | 9.88e-05 | 799 | 143 | 16 | gudmap_kidney_adult_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_top-relative-expression-ranked_500 | CMBL SGMS2 SLC19A3 SLC6A15 SLC16A12 SLC5A1 SLC7A8 SLC10A2 SLC12A3 SLC5A8 SLC16A7 | 1.44e-04 | 424 | 143 | 11 | gudmap_kidney_adult_RenalCortexMixed_Std_500 |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | CYBB FPR1 ABCA9 EDNRB SLC7A8 CD9 TSPAN4 C5AR1 ATP1A3 SLC16A7 GPRC5B | 1.91e-04 | 438 | 143 | 11 | GSM605850_500 |
| CoexpressionAtlas | cerebral cortex | CACNA1A ILDR2 CACNA1E HTR2A CLIP2 PCDHA7 SLC6A15 SLC1A3 CHRM3 SLC4A3 SLC22A17 SLC12A5 SLC8A3 GPR61 NRXN2 P2RX6 UCHL1 SORCS2 CACNA1I CACNA1G ATP1A3 GPRC5B | 2.26e-04 | 1428 | 143 | 22 | cerebral cortex |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#3 | CACNA1E SLC15A3 SLC1A3 SLC4A3 SLC5A1 SLC6A12 SLC8A1 KCNJ12 SCN5A | 2.65e-04 | 311 | 143 | 9 | JC_iEC_2500_K3 |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8-.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 2.75e-04 | 85 | 143 | 5 | GSM605843_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.Sp, GR1-PE CD11c-eFluor750 CD8-eFluor480 CD45-APC B220, Spleen, avg-3 | 2.90e-04 | 86 | 143 | 5 | GSM605840_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.SLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-3 | 3.06e-04 | 87 | 143 | 5 | GSM854299_100 | |
| CoexpressionAtlas | Plasmacytoid, DC.pDC.8+.MLN, B220-FITC CD45-APC CD11c-eFluor780 GR1-PE CD8-eFlu, Lymph Node, avg-2 | 3.06e-04 | 87 | 143 | 5 | GSM854297_100 | |
| ToppCell | Transverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass | CYBB FPR1 SLC15A3 SLC1A3 ABCA9 ARHGEF10L SLC12A5 NRXN2 SCN9A C5AR1 SLC12A7 | 9.65e-11 | 199 | 152 | 11 | facf79c256db5ae57bdb613e86ec90616a6f67ca |
| ToppCell | Transverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype | CYBB FPR1 SLC15A3 SLC1A3 ABCA9 ARHGEF10L SLC12A5 NRXN2 SCN9A C5AR1 SLC12A7 | 9.65e-11 | 199 | 152 | 11 | dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue | CYBB SGMS2 FPR1 FPR2 SLC19A3 SLC15A3 SLC1A3 ARHGEF10L SLC8A1 C5AR1 | 5.39e-10 | 176 | 152 | 10 | 4be270f6bb7da4070f972aca403109751646d155 |
| ToppCell | Immune_cells-Dendritic_cells|Immune_cells / Lineage and Cell class | CCR9 SLC44A2 SPNS3 CALHM2 SEMA4C SLC41A2 NRXN2 STOML1 ATP1A1 | 1.36e-08 | 182 | 152 | 9 | 99c7d4f1e7cd745643ba64b59190113bcd4e348e |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-08 | 182 | 152 | 9 | ccfee33de0faebbe69099d4ff3c3971f6a708b99 | |
| ToppCell | 3'_v3-Lung|World / Manually curated celltypes from each tissue | 2.58e-08 | 196 | 152 | 9 | a04f8384b734ce67ec402e64bd891a6274f04744 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CYBB FPR1 FPR2 SLC19A3 SLC15A3 SLC1A3 ARHGEF10L SLC7A8 C5AR1 | 3.07e-08 | 200 | 152 | 9 | 6e50272d172b491200d9a255ed08e6d6998cfe02 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CYBB FPR1 FPR2 SLC19A3 SLC15A3 SLC1A3 ARHGEF10L SLC7A8 C5AR1 | 3.07e-08 | 200 | 152 | 9 | 840be665639a53ba9bafc19f7a81ca1e0436e329 |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-08 | 200 | 152 | 9 | db7acee26a02c0836923b0a92174f65c51fafab1 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-08 | 157 | 152 | 8 | 2b60de520edf167f5ca790b478557a778435b3d9 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-07 | 168 | 152 | 8 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-07 | 168 | 152 | 8 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-07 | 168 | 152 | 8 | c861f80aa12caf54a94d93e38539ff41dc5227a6 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.24e-07 | 169 | 152 | 8 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-07 | 169 | 152 | 8 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | facs-Marrow-Granulocytes|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-07 | 171 | 152 | 8 | 1701dedf0c18751db6c9fee3d93fff150ed0e17f | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intermediate_macrophages|Liver / Manually curated celltypes from each tissue | 1.36e-07 | 171 | 152 | 8 | 25e0333743affdb662223fb5220b8a61fa02ad9f | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 172 | 152 | 8 | bc1b889ac5e07b8324ae5837eca911f9c865e959 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 172 | 152 | 8 | 0457ccc18697aaec44b7c30ae157aae8f48d8785 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-07 | 172 | 152 | 8 | ba70b6110b70afb1870e8dcaf58c507b8c7d918e | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-07 | 176 | 152 | 8 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-07 | 176 | 152 | 8 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.29e-07 | 183 | 152 | 8 | 745271bfe15e94a58157cd97d771e610f964341b | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-07 | 185 | 152 | 8 | 65dcb0a7ee64990a34a87c167b44497107f035ee | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-07 | 189 | 152 | 8 | a59025e82fabd9d60e2438dee85b2644478cc7c8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.17e-07 | 191 | 152 | 8 | 63d4226a8b59f648bdc9f41e4b2d750dfa342034 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.30e-07 | 192 | 152 | 8 | 62eac1b8aed4fb924946b58c0237313f697a0136 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-07 | 193 | 152 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-07 | 193 | 152 | 8 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.43e-07 | 193 | 152 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 3.86e-07 | 196 | 152 | 8 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic-Nonclassical_monocytes|bone_marrow / Manually curated celltypes from each tissue | 4.01e-07 | 197 | 152 | 8 | dcf1e74b7c21466d38d68f44d404bce14ade2805 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.16e-07 | 198 | 152 | 8 | 8d629492d2199de8e036c19e9dacceb9c9e721a0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.16e-07 | 198 | 152 | 8 | dc59442e6a5127d3071a036c206732a21e456a17 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.16e-07 | 198 | 152 | 8 | 6e6af8fad09f8e48b3f2ce463d5773b6a69864d1 | |
| ToppCell | mLN-(4)_Monocyte|mLN / shred on region, Cell_type, and subtype | 4.33e-07 | 199 | 152 | 8 | 6795ff31f92580195c9db776951f99d647484d24 | |
| ToppCell | mLN-Monocyte|mLN / Region, Cell class and subclass | 4.33e-07 | 199 | 152 | 8 | 241f790cd5d8a9b2451333deecc826a673bae70a | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-07 | 199 | 152 | 8 | 7648860058eec66019b574ad840d6f5cfa4476d9 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.33e-07 | 199 | 152 | 8 | d3f77acb36ac7c56a47ca98b695f46ae5b9ecd12 | |
| ToppCell | mLN-Monocyte-Monocyte|mLN / Region, Cell class and subclass | 4.33e-07 | 199 | 152 | 8 | dcee372774c169a3048bdaed3734b3215bf8ffad | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-07 | 199 | 152 | 8 | 4b6d49b96bfcd6604b082bab620ae03276520885 | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Myeloid-Macrophage_alveolar|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.33e-07 | 199 | 152 | 8 | 91c72e06a7416671977430211c57938e39e8195e | |
| ToppCell | mLN-(4)_Monocyte-(40)_Monocyte|mLN / shred on region, Cell_type, and subtype | 4.33e-07 | 199 | 152 | 8 | bcbb1eee8d79bf670dbe113094c3a292b135ce2f | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.33e-07 | 199 | 152 | 8 | 01c2721bc82cd672e9477029b4a7ecc77e2f1b00 | |
| ToppCell | Sigmoid-(4)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 4.49e-07 | 200 | 152 | 8 | 7f3920a0434d5199c6c8f0b3064a305bb0d87b60 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.49e-07 | 200 | 152 | 8 | 3a69149055ac8511eb789dbcc89fd17ccfb2ea6b | |
| ToppCell | Sigmoid-Monocyte-Monocyte|Sigmoid / Region, Cell class and subclass | 4.49e-07 | 200 | 152 | 8 | 010ca36970cb8894bdbca08779c0ecf56be22fc9 | |
| ToppCell | Sigmoid-Monocyte|Sigmoid / Region, Cell class and subclass | 4.49e-07 | 200 | 152 | 8 | c41bd6ec0f2262fce5cadb37a400d487e6662f49 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-07 | 200 | 152 | 8 | c325dc52e4bf3829a35905b956784ca3e9191926 | |
| ToppCell | Sigmoid-(4)_Monocyte-(40)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 4.49e-07 | 200 | 152 | 8 | 576c0a1098e6a934448705de3673ef798fcf1b26 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.49e-07 | 200 | 152 | 8 | b92804f15586e1802fdd931d6dfe742be8466944 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-07 | 145 | 152 | 7 | ab0e254a8d01021619853a6c175f620ccef217d8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.83e-07 | 145 | 152 | 7 | 2beb4ea3838796c580076ab7769de877a3a0552c | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-neutrophil|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-06 | 157 | 152 | 7 | e96241db2b5ff52b230e3e33207e7bb968900cab | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-neutrophil-neutrophil|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-06 | 157 | 152 | 7 | 07a0f8d29a3111be670eae030a91474465eba734 | |
| ToppCell | facs-Lung-Endomucin-24m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-06 | 159 | 152 | 7 | 886cbaef39a3517514a3896b6b960d01a3af043d | |
| ToppCell | facs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 160 | 152 | 7 | bd5fa7959bfe81011b8d798535b73ea1eee008b3 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.38e-06 | 161 | 152 | 7 | 6cacae4a759ace763597ee394cff498dc5d96f74 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-06 | 161 | 152 | 7 | 65888250b8c1da6a8f9b5376e086a3769a1cbbd8 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-06 | 162 | 152 | 7 | 71d7849108a1b59beff40e46000172c45a2f5439 | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 164 | 152 | 7 | 939d4e3911fce185b986639c815de0a0389f6cfd | |
| ToppCell | droplet-Fat-Mat-18m-Myeloid-monocyte|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 164 | 152 | 7 | a27b9b3380f29bb17c9f787423f2591f2b9cf33e | |
| ToppCell | droplet-Liver-LIVER-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-06 | 164 | 152 | 7 | 3281f2452cc6b11f3e030a3942002b9457dde6fe | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 166 | 152 | 7 | 03a47b8687f54955e84df1edcb230db332c4ca8f | |
| ToppCell | facs-MAT-Fat-24m-Myeloid|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 168 | 152 | 7 | 6514a27a54ea0f07172b3a73270250143a7b14f0 | |
| ToppCell | facs-MAT-Fat-24m-Myeloid-nan|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 168 | 152 | 7 | 0b6bb335e93476b13955543eeb487243b0067369 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-06 | 168 | 152 | 7 | c0aef5947b1d7e2c81a7481c509feda1687fcd7f | |
| ToppCell | PND07-28-samps-Myeloid|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.83e-06 | 168 | 152 | 7 | 87512f9e5e95333e7ffc6efa1e93bab2ba9154c6 | |
| ToppCell | facs-BAT-Fat-24m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 170 | 152 | 7 | 53916d85f0d6c7e5ef3d900d6ead946f75e32567 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 170 | 152 | 7 | 8fd0a55266066a51266ab616c38c883e2680bcf4 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-06 | 171 | 152 | 7 | b327fb7813a3cdae06c8a4f8a0c256e9a20132f6 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.14e-06 | 172 | 152 | 7 | 584af6537685cb459bf0fc298e6f46872016c116 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 172 | 152 | 7 | 30916a902c151907745756d14327e24adc34afef | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.31e-06 | 174 | 152 | 7 | 268abfc4d53a3ba3931dbcafffef09a72ea0edfa | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.40e-06 | 175 | 152 | 7 | 36cb3c8116bd467ee5da0630d8b3d3e4afcc2ded | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_macrophage_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.50e-06 | 176 | 152 | 7 | 98176bf3c961d5262593e2d5d002836adb010e13 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.50e-06 | 176 | 152 | 7 | e74ad0db3b05897edcfabeb11008ede2b9eeb638 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 177 | 152 | 7 | 43883b65b1e03043a24fc40c84c50bac81960c12 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-06 | 177 | 152 | 7 | 9de6a82b7fb72d20361947f7ac95bb1fa73fc2ff | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-06 | 177 | 152 | 7 | 71919b5c9bfa87fdd2cd44dfa057b66ea081be5d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-06 | 178 | 152 | 7 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-06 | 179 | 152 | 7 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_33|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.79e-06 | 179 | 152 | 7 | 13d80ae2e43a5daad0aeb5f47338efca2c58800a | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 181 | 152 | 7 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-06 | 181 | 152 | 7 | fb64da1dde37fe6ba7de2586cd58848ac1974f24 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-06 | 182 | 152 | 7 | 1fb9bdf2e9f0a9c230f109b471672f9c31e27c82 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.23e-06 | 183 | 152 | 7 | 36b194e366a14ebc4df187bf31c902be3797bfcc | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.35e-06 | 184 | 152 | 7 | 8e5fc2bdd3071e782aa8c56b8a39f8ea8f03f623 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-06 | 185 | 152 | 7 | 1ecfca049c0c1110fd1b2256db7cb7abda6afb04 | |
| ToppCell | facs-Heart-LA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-06 | 185 | 152 | 7 | b6df1412b579d40ed5df806f9c54bd1fbb9a1e15 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-06 | 187 | 152 | 7 | 8e1d6d25db5b5c91a651bb2d66edfcf073a31704 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.73e-06 | 187 | 152 | 7 | 3b1439018e265a61d9599e307a202e3c2f60ed32 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.73e-06 | 187 | 152 | 7 | e99bc27d212c74da37770297122a4b30445ccd0d | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 3.86e-06 | 188 | 152 | 7 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.86e-06 | 188 | 152 | 7 | fbf176b48b89c234e4e1e64739afc836bed78a96 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 188 | 152 | 7 | d2d2b6c49448da24f457cedcd213f68841834a99 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam_____kidney_distal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-06 | 188 | 152 | 7 | ab6fa1beff91584d9303c2a33735de89aae8d5cd | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-06 | 189 | 152 | 7 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | COVID-19-lung-Lymphatic_EC|lung / Disease (COVID-19 only), tissue and cell type | 4.00e-06 | 189 | 152 | 7 | c8db9aaf54ea3cc96c4a2f777c3389e0f31f67f3 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_macrophage|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.00e-06 | 189 | 152 | 7 | 440c422369de1c49112d18cf8c506a2a3a81f6ba | |
| Computational | Membranal receptors. | HTR2A ATP7B CCR9 FPR1 FPR2 SLC13A2 SLC4A3 RHAG EDNRB CD82 SLC12A3 CD9 SLC22A4 TSPAN4 C5AR1 GPRC5B | 5.83e-07 | 517 | 77 | 16 | MODULE_64 |
| Computational | Genes in the cancer module 162. | 8.70e-06 | 19 | 77 | 4 | MODULE_162 | |
| Computational | Genes in the cancer module 218. | 1.08e-05 | 20 | 77 | 4 | MODULE_218 | |
| Computational | Genes in the cancer module 134. | 5.79e-05 | 30 | 77 | 4 | MODULE_134 | |
| Computational | Genes in the cancer module 146. | 8.66e-05 | 102 | 77 | 6 | MODULE_146 | |
| Computational | Genes in the cancer module 288. | 1.34e-04 | 37 | 77 | 4 | MODULE_288 | |
| Computational | Peptide and AA transporters. | 2.67e-04 | 18 | 77 | 3 | MODULE_368 | |
| Computational | GPCR signaling pathways (immune and neuro). | 4.52e-04 | 90 | 77 | 5 | MODULE_375 | |
| Computational | Genes in the cancer module 71. | 4.93e-04 | 22 | 77 | 3 | MODULE_71 | |
| Drug | sodium | CACNA1D FLT4 ATP7B SLC6A15 SLC12A8 SLC46A1 SLC7A6 SLC13A2 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC7A8 SLC6A12 SLC8A1 SLC8A3 SLC9A1 SLC10A2 SLC12A3 SLC15A1 P2RX6 SLC22A4 KCNJ12 SCN4A SCN5A SCN9A SLC10A6 SLC13A5 CACNA1H SLC5A8 ATP1A1 ATP1A3 ATP2B4 | 1.19e-15 | 944 | 147 | 33 | CID000000923 |
| Drug | bepridil | CACNA1A CACNA1D CACNA1E CACNA1F SLC8A3 SCN4A SCN5A SCN9A ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G ATP1A1 | 8.65e-14 | 126 | 147 | 14 | CID000002351 |
| Drug | verapamil | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A ABCA9 SLC9A1 CD9 MAP4K5 SLC22A4 KCNJ12 SCN4A SCN5A SCN9A ORAI3 CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 ATP2B4 | 7.45e-12 | 490 | 147 | 21 | CID000002520 |
| Drug | lamotrigine | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SLC35A2 SCN5A SCN9A ORAI3 CACNA1I CACNA1H CACNA1G | 1.29e-11 | 116 | 147 | 12 | CID000003878 |
| Drug | Barium | CACNA1A CACNA1D CACNA1E CACNA1F SLC8A1 KCNJ12 CACNA1I CACNA1H CACNA1G SLC12A7 | 3.52e-11 | 72 | 147 | 10 | ctd:D001464 |
| Drug | 3,4-dihydroquinazoline | 6.25e-11 | 6 | 147 | 5 | CID000583065 | |
| Drug | aldosterone | CACNA1A CACNA1D CACNA1E CACNA1F BCL2A1 SLC7A6 EDNRB SLC5A1 SLC9A1 SLC12A3 CLDN17 SCN4A SCN9A CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 | 1.05e-10 | 397 | 147 | 18 | CID000005839 |
| Drug | potassium | CACNA1A CACNA1D CACNA1E CACNA1F FLT4 SLC12A8 SLC1A3 SLC5A1 SLC12A5 SLC7A8 SLC8A1 SLC8A3 SLC9A1 SLC12A3 MAP4K5 KCNJ12 SCN4A SCN5A SCN9A ORAI3 CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 SLC12A7 ATP2B4 | 2.91e-10 | 1008 | 147 | 27 | CID000000813 |
| Drug | Verapamil | 4.96e-10 | 16 | 147 | 6 | DB00661 | |
| Drug | Zonisamide | 7.63e-10 | 17 | 147 | 6 | DB00909 | |
| Drug | isradipine | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SCN9A ORAI3 CACNA1I CACNA1H CACNA1G | 9.74e-10 | 100 | 147 | 10 | CID000003784 |
| Drug | Cinnarizine | 1.29e-09 | 9 | 147 | 5 | DB00568 | |
| Drug | CNS 1145 | 1.50e-09 | 33 | 147 | 7 | CID000190902 | |
| Drug | IHC-64 | 1.50e-09 | 33 | 147 | 7 | CID000162753 | |
| Drug | nisoldipine | CACNA1A CACNA1D CACNA1E CACNA1F SLC5A1 ORAI3 CACNA1I CACNA1H CACNA1G | 1.90e-09 | 78 | 147 | 9 | CID000004499 |
| Drug | isovalerate | CACNA1A CACNA1D CACNA1E DAP3 CD9 SCN5A ORAI3 SLC13A5 CACNA1I CACNA1H CACNA1G | 2.32e-09 | 143 | 147 | 11 | CID000010430 |
| Drug | NSC7524 | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 | 2.48e-09 | 182 | 147 | 12 | CID000005657 |
| Drug | Cinildipine | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 2.72e-09 | 56 | 147 | 8 | CID000002752 |
| Drug | Calcium | CYBB CACNA1A CACNA1D CACNA1E CACNA1F HTR2A CCR9 SLC5A1 SLC12A5 SLC8A1 SLC8A3 SLC9A1 SCN9A CACNA1I CACNA1H CACNA1G ATP1A1 ATP2B4 | 3.33e-09 | 493 | 147 | 18 | ctd:D002118 |
| Drug | Mibefradil | 4.69e-09 | 11 | 147 | 5 | DB01388 | |
| Drug | procaine | CACNA1A CACNA1D CACNA1E CACNA1F SLC10A2 SCN4A SCN9A ORAI3 CACNA1I CACNA1H CACNA1G | 4.75e-09 | 153 | 147 | 11 | CID000004914 |
| Drug | nilvadipine | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 4.80e-09 | 60 | 147 | 8 | CID000004494 |
| Drug | IAA-94 | CACNA1A CACNA1D CACNA1E CACNA1F FLT4 CACNA1I CACNA1H CACNA1G | 5.50e-09 | 61 | 147 | 8 | CID000003667 |
| Drug | lercanidipine | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 7.15e-09 | 63 | 147 | 8 | CID000065866 |
| Drug | AC1L2VU3 | 8.00e-09 | 12 | 147 | 5 | CID000129572 | |
| Drug | pimozide | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A CHRM3 ORAI3 CACNA1I CACNA1H CACNA1G | 1.02e-08 | 127 | 147 | 10 | CID000016362 |
| Drug | gallopamil | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 1.18e-08 | 67 | 147 | 8 | CID000001234 |
| Drug | bumetanide | SLC12A8 SLC13A2 SLC1A3 SLC5A1 SLC12A5 SLC9A1 SLC12A3 SLC15A1 SLC13A5 ATP1A1 ATP1A3 SLC12A7 | 1.18e-08 | 209 | 147 | 12 | CID000002471 |
| Drug | gabapentin | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SCN5A SCN9A ORAI3 CACNA1I CACNA1H CACNA1G | 1.35e-08 | 169 | 147 | 11 | CID000003446 |
| Drug | nitrendipine | CACNA1A CACNA1D CACNA1E CACNA1F MAP4K5 ORAI3 CACNA1I CACNA1H CACNA1G | 1.47e-08 | 98 | 147 | 9 | CID000004507 |
| Drug | AC1L2AC7 | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 1.49e-08 | 69 | 147 | 8 | CID000068733 |
| Drug | amiloride | CACNA1A CACNA1D SLC19A3 SLC16A12 SLC9A1 SLC12A3 KCNJ12 SCN4A SCN9A ORAI3 CACNA1I CACNA1H ATP1A1 ATP1A3 | 1.80e-08 | 315 | 147 | 14 | CID000016230 |
| Drug | riluzole | CACNA1A CACNA1D CACNA1E CACNA1F SLC1A3 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G | 1.82e-08 | 174 | 147 | 11 | CID000005070 |
| Drug | lanthanum | CACNA1A CACNA1D CACNA1E CACNA1F MAP4K5 ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 1.96e-08 | 136 | 147 | 10 | CID000023926 |
| Drug | phenytoin | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SLC35A2 SCN5A SCN9A ORAI3 CACNA1I CACNA1H CACNA1G | 1.99e-08 | 219 | 147 | 12 | CID000001775 |
| Drug | CAS 298-57-7 | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 2.35e-08 | 73 | 147 | 8 | CID000002761 |
| Drug | ethosuximide | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 2.62e-08 | 74 | 147 | 8 | CID000003291 |
| Drug | loperamide | CACNA1A CACNA1D CACNA1E CACNA1F SLC5A1 ORAI3 CACNA1I CACNA1H CACNA1G | 2.70e-08 | 105 | 147 | 9 | CID000003954 |
| Drug | nimodipine | CACNA1A CACNA1D CACNA1E CACNA1F SLC39A6 ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 3.63e-08 | 145 | 147 | 10 | CID000004497 |
| Drug | nicardipine | CACNA1A CACNA1D CACNA1E CACNA1F EDNRB MAP4K5 ORAI3 CACNA1I CACNA1H CACNA1G | 3.63e-08 | 145 | 147 | 10 | CID000004473 |
| Drug | pentasulfane | 4.32e-08 | 16 | 147 | 5 | CID000448216 | |
| Drug | Bay K 8644 | CACNA1A CACNA1D CACNA1E CACNA1F MAP4K5 ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 5.01e-08 | 150 | 147 | 10 | CID000002303 |
| Drug | dihydropyridine | CACNA1A CACNA1D CACNA1E CACNA1F SLC9A1 SCN4A ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 5.30e-08 | 193 | 147 | 11 | CID000104822 |
| Drug | LY215840 | 5.75e-08 | 7 | 147 | 4 | CID000132049 | |
| Drug | Sodium | 7.18e-08 | 84 | 147 | 8 | ctd:D012964 | |
| Drug | butylparaben | CACNA1A CACNA1D CACNA1E CACNA1F SLC1A3 FASN NRXN2 CACNA1I CACNA1H CACNA1G | 7.71e-08 | 157 | 147 | 10 | ctd:C038091 |
| Drug | tetradotoxin | CACNA1A CACNA1D CACNA1E HTR2A EDNRB SLC12A5 P2RX6 SCN4A SCN5A SCN9A CACNA1I CACNA1H CACNA1G ATP1A1 ATP1A3 | 1.25e-07 | 428 | 147 | 15 | CID000020382 |
| Drug | enzacamene | CACNA1A CACNA1D CACNA1E CACNA1F SLC1A3 NRXN2 CACNA1I CACNA1H CACNA1G | 1.62e-07 | 129 | 147 | 9 | ctd:C038939 |
| Drug | D-myo-inositol-1,4,5-triphosphate | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A FPR1 FPR2 ZDHHC17 EDNRB SLC8A3 TSPAN10 ORAI3 CACNA1I CACNA1H CACNA1G ATP1A3 ATP2B4 | 1.66e-07 | 568 | 147 | 17 | CID000000806 |
| Drug | mibefradil | 1.85e-07 | 64 | 147 | 7 | CID000060662 | |
| Drug | manidipine | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 1.89e-07 | 95 | 147 | 8 | CID000004008 |
| Drug | furosemide | CYBB FLT4 SLC12A8 SLC13A2 SLC1A3 SLC5A1 SLC12A5 SLC9A1 SLC12A3 ATP1A1 ATP1A3 SLC12A7 | 2.13e-07 | 272 | 147 | 12 | CID000003440 |
| Drug | AC1L1TJF | 2.29e-07 | 66 | 147 | 7 | CID000003377 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 2.64e-07 | 3 | 147 | 3 | CID010679219 | |
| Drug | AC1L1KS5 | CACNA1A CACNA1D CMKLR2 CACNA1E CACNA1F FPR1 FPR2 EDNRB CACNA1I CACNA1H CACNA1G C5AR1 ATP2B4 | 2.76e-07 | 334 | 147 | 13 | CID000005631 |
| Drug | octylmethoxycinnamate | CACNA1A CACNA1D CACNA1E CACNA1F SLC1A3 NRXN2 CACNA1I CACNA1H CACNA1G | 3.06e-07 | 139 | 147 | 9 | ctd:C118580 |
| Drug | methanethiosulfonate | 3.53e-07 | 103 | 147 | 8 | CID004188587 | |
| Drug | pyraclofos | 4.41e-07 | 106 | 147 | 8 | CID000093460 | |
| Drug | NSC759576 | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A FPR1 ORAI3 CACNA1I CACNA1H CACNA1G | 4.79e-07 | 191 | 147 | 10 | CID000003075 |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 7.96e-07 | 79 | 147 | 7 | CID005287890 | |
| Drug | KW-3049 | 8.22e-07 | 50 | 147 | 6 | CID000002324 | |
| Drug | tetralol | 1.14e-06 | 13 | 147 | 4 | CID000010747 | |
| Drug | oxcarbazepine | 1.31e-06 | 30 | 147 | 5 | CID000034312 | |
| Drug | probenecid | 1.37e-06 | 123 | 147 | 8 | CID000004911 | |
| Drug | GTP[S] | CACNA1A CACNA1D CMKLR2 CACNA1E HTR2A FPR1 FPR2 SLC9A1 KCNJ12 SCN4A SCN9A ORAI3 CACNA1I CACNA1H C5AR1 HCRTR2 | 1.46e-06 | 591 | 147 | 16 | CID000001764 |
| Drug | sulfinpyrazone | 1.54e-06 | 87 | 147 | 7 | CID000005342 | |
| Drug | nalidixic acid | FLT4 EDNRB SLC5A1 SLC12A5 SLC8A1 SLC8A3 SLC9A1 SLC12A3 SCN5A ATP1A1 ATP1A3 | 1.94e-06 | 277 | 147 | 11 | CID000004421 |
| Drug | butamben | 2.15e-06 | 15 | 147 | 4 | CID000002482 | |
| Drug | Flunarizine | 2.61e-06 | 5 | 147 | 3 | DB04841 | |
| Drug | glycylsarcosine | 2.91e-06 | 35 | 147 | 5 | CID000093131 | |
| Drug | chloride | FLT4 SLC25A20 HTR2A ATP7B SLC6A15 SLC12A8 BCL2A1 SLC13A2 SLC1A3 SLC4A3 SLC5A1 SLC12A5 SLC6A12 SLC9A1 SLC12A3 SLC15A1 SCN4A SLC13A5 ATP1A1 ATP1A3 SLC12A7 | 2.95e-06 | 1029 | 147 | 21 | CID000000312 |
| Drug | nifedipine | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A ATP7B EDNRB SLC12A5 ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 3.11e-06 | 415 | 147 | 13 | CID000004485 |
| Drug | isotetrandrine | 3.20e-06 | 97 | 147 | 7 | CID000005422 | |
| Drug | homovanillic acid | 3.20e-06 | 97 | 147 | 7 | CID000001738 | |
| Drug | tetraethylammonium | CACNA1D FLT4 SLC19A3 NRXN2 SLC22A4 KCNJ12 SCN4A SCN9A ATP1A1 ATP1A3 | 3.25e-06 | 236 | 147 | 10 | CID000005413 |
| Drug | K-Cl | CACNA1A CACNA1D CACNA1E FLT4 HTR2A FPR2 EDNRB SLC12A5 SLC9A1 SLC12A3 KCNJ12 ATP1A1 ATP1A3 SLC12A7 ATP2B4 | 4.20e-06 | 567 | 147 | 15 | CID000004873 |
| Drug | baclofen | CACNA1A CACNA1D CACNA1E CACNA1F KCNJ12 CACNA1I CACNA1H CACNA1G ATP1A3 | 4.33e-06 | 191 | 147 | 9 | CID000002284 |
| Drug | Dantrolene-13C3 | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 4.71e-06 | 145 | 147 | 8 | CID000002951 |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | CACNA1D CMKLR2 ZDHHC17 EML3 EDNRB SLC12A3 PNMA8A C5AR1 ATP2B4 | 5.35e-06 | 196 | 147 | 9 | 3564_UP |
| Drug | gadolinium | CACNA1A CACNA1D CACNA1E CACNA1F FLT4 ORAI3 CACNA1I CACNA1H CACNA1G | 6.05e-06 | 199 | 147 | 9 | CID000023982 |
| Drug | nsc25485 | FLT4 SLC8A1 SLC8A3 SLC9A1 CD9 SCN4A SCN9A SLC10A6 ATP1A1 ATP1A3 ATP2B4 | 6.08e-06 | 312 | 147 | 11 | CID000004605 |
| Drug | hydride | CACNA1E SLC44A2 SLC46A1 SLC15A3 SLC13A2 SLC1A3 SLC5A1 FASN SLC9A1 SLC12A3 SLC15A1 MAP4K5 CACNA1I CACNA1H CACNA1G ATP1A3 SLC16A7 ATP2B4 | 7.68e-06 | 835 | 147 | 18 | CID000000783 |
| Drug | 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid | FLT4 SLC46A1 SLC13A2 SLC1A3 SLC4A3 SLC9A1 P2RX6 SLC13A5 SLC16A7 | 8.00e-06 | 206 | 147 | 9 | CID000040600 |
| Drug | AC1NBU2S | 1.11e-05 | 117 | 147 | 7 | CID004473765 | |
| Drug | NiCl2 | 1.24e-05 | 119 | 147 | 7 | CID000024385 | |
| Drug | leucine | 1.33e-05 | 167 | 147 | 8 | CID000000857 | |
| Drug | Bepridil | 1.44e-05 | 8 | 147 | 3 | DB01244 | |
| Drug | L-valine methyl ester hydrochloride | 1.44e-05 | 8 | 147 | 3 | CID000094285 | |
| Drug | felodipine | CACNA1A CACNA1D CACNA1E CACNA1F ORAI3 CACNA1I CACNA1H CACNA1G | 1.45e-05 | 169 | 147 | 8 | CID000003333 |
| Drug | U46619 | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A EDNRB CACNA1I CACNA1H CACNA1G C5AR1 | 1.70e-05 | 285 | 147 | 10 | CID000005618 |
| Drug | amlodipine | 1.80e-05 | 126 | 147 | 7 | CID000002162 | |
| Drug | hydroxamates | 1.90e-05 | 25 | 147 | 4 | CID000033630 | |
| Drug | myo-inositol | CACNA1A CACNA1D CMKLR2 CACNA1E CACNA1F HTR2A FPR1 FPR2 EDNRB SLC5A1 SLC6A12 P2RX6 TSPAN10 CACNA1I CACNA1H CACNA1G ATP2B4 | 2.00e-05 | 811 | 147 | 17 | CID000000892 |
| Drug | cimetidine | 2.20e-05 | 179 | 147 | 8 | CID000002756 | |
| Drug | noradrealine | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A EDNRB SLC10A2 P2RX6 MAP4K5 CACNA1I CACNA1H CACNA1G ATP1A3 STX7 | 2.25e-05 | 575 | 147 | 14 | CID000000951 |
| Drug | Chlorine | CACNA1A ATP7B SLC6A15 SLC6A12 CD9 NRXN2 SLC15A1 AGER SCN4A C5AR1 ATP1A1 | 2.75e-05 | 367 | 147 | 11 | ctd:D002713 |
| Drug | CMP-Neu5Ac | 3.72e-05 | 141 | 147 | 7 | CID000000316 | |
| Drug | valproate | CACNA1A CACNA1D CACNA1E CACNA1F SCN4A SLC35A2 SCN9A SLC13A5 CACNA1I CACNA1H CACNA1G | 3.87e-05 | 381 | 147 | 11 | CID000003121 |
| Drug | halothane | CACNA1A CACNA1D CACNA1E CACNA1F HTR2A ORAI3 CACNA1I CACNA1H CACNA1G ATP2B4 | 3.87e-05 | 314 | 147 | 10 | CID000003562 |
| Drug | Ranolazine | 4.14e-05 | 2 | 147 | 2 | DB00243 | |
| Disease | epilepsy (implicated_via_orthology) | CACNA1A CACNA1E SLC13A2 SLC1A3 SLC12A5 SLC12A3 SCN4A SCN5A SCN9A SLC13A5 ATP1A1 ATP1A3 SLC12A7 | 2.20e-12 | 163 | 148 | 13 | DOID:1826 (implicated_via_orthology) |
| Disease | Alternating hemiplegia of childhood | 4.93e-07 | 4 | 148 | 3 | C0338488 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 4.26e-06 | 7 | 148 | 3 | DOID:0060178 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.45e-05 | 10 | 148 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.45e-05 | 10 | 148 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | reticulocyte count | CMKLR2 SLC25A20 AIMP2 SLC44A2 SLC12A8 BCL2A1 LCP1 RHAG SLC12A5 CD82 CD9 MAP4K5 SLC22A4 KCNJ12 TMC8 STX7 ATP2B4 | 2.07e-05 | 1045 | 148 | 17 | EFO_0007986 |
| Disease | reticulocyte measurement | SMIM24 CMKLR2 SLC25A20 AIMP2 SLC44A2 SLC12A8 LCP1 SLC22A17 RHAG CD82 CD9 MAP4K5 KCNJ12 TMC8 STX7 SLC12A7 ATP2B4 | 2.28e-05 | 1053 | 148 | 17 | EFO_0010700 |
| Disease | occipital horn syndrome (implicated_via_orthology) | 2.50e-05 | 2 | 148 | 2 | DOID:0111272 (implicated_via_orthology) | |
| Disease | THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2 | 2.50e-05 | 2 | 148 | 2 | C2750473 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.63e-05 | 12 | 148 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Dystonia | 7.45e-05 | 86 | 148 | 5 | C0013421 | |
| Disease | Hypokalemic periodic paralysis type 1 | 7.47e-05 | 3 | 148 | 2 | C3714580 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 7.47e-05 | 3 | 148 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | abdominal adipose tissue measurement | 1.47e-04 | 53 | 148 | 4 | EFO_0803316 | |
| Disease | migraine (implicated_via_orthology) | 1.49e-04 | 4 | 148 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Timothy syndrome (implicated_via_orthology) | 1.49e-04 | 4 | 148 | 2 | DOID:0060173 (implicated_via_orthology) | |
| Disease | renal fibrosis (is_marker_for) | 1.49e-04 | 4 | 148 | 2 | DOID:0050855 (is_marker_for) | |
| Disease | longitudinal BMI measurement, non-small cell lung carcinoma | 1.49e-04 | 4 | 148 | 2 | EFO_0003060, EFO_0005937 | |
| Disease | transmembrane protein 132A measurement | 1.49e-04 | 4 | 148 | 2 | EFO_0802150 | |
| Disease | metal metabolism disorder (implicated_via_orthology) | 1.49e-04 | 4 | 148 | 2 | DOID:896 (implicated_via_orthology) | |
| Disease | Hereditary episodic ataxia | 1.49e-04 | 4 | 148 | 2 | cv:C1720189 | |
| Disease | Congestive heart failure | 2.38e-04 | 110 | 148 | 5 | C0018802 | |
| Disease | Heart failure | 2.38e-04 | 110 | 148 | 5 | C0018801 | |
| Disease | Left-Sided Heart Failure | 2.38e-04 | 110 | 148 | 5 | C0023212 | |
| Disease | Heart Failure, Right-Sided | 2.38e-04 | 110 | 148 | 5 | C0235527 | |
| Disease | Heart Decompensation | 2.38e-04 | 110 | 148 | 5 | C1961112 | |
| Disease | Myocardial Failure | 2.38e-04 | 110 | 148 | 5 | C1959583 | |
| Disease | Wilson disease (implicated_via_orthology) | 2.47e-04 | 5 | 148 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | Kohlschutter-Tonz syndrome (implicated_via_orthology) | 2.47e-04 | 5 | 148 | 2 | DOID:0111668 (implicated_via_orthology) | |
| Disease | Menkes disease (implicated_via_orthology) | 2.47e-04 | 5 | 148 | 2 | DOID:1838 (implicated_via_orthology) | |
| Disease | Grand Mal Status Epilepticus | 3.64e-04 | 67 | 148 | 4 | C0311335 | |
| Disease | Status Epilepticus, Subclinical | 3.64e-04 | 67 | 148 | 4 | C0751522 | |
| Disease | Simple Partial Status Epilepticus | 3.64e-04 | 67 | 148 | 4 | C0751524 | |
| Disease | Non-Convulsive Status Epilepticus | 3.64e-04 | 67 | 148 | 4 | C0751523 | |
| Disease | Petit mal status | 3.64e-04 | 67 | 148 | 4 | C0270823 | |
| Disease | Complex Partial Status Epilepticus | 3.64e-04 | 67 | 148 | 4 | C0393734 | |
| Disease | Conn Syndrome | 3.70e-04 | 6 | 148 | 2 | C1384514 | |
| Disease | Sick Sinus Syndrome | 3.70e-04 | 6 | 148 | 2 | C0037052 | |
| Disease | Hyperaldosteronism | 3.70e-04 | 6 | 148 | 2 | C0020428 | |
| Disease | Status Epilepticus | 3.86e-04 | 68 | 148 | 4 | C0038220 | |
| Disease | triacylglycerol 56:7 measurement | 4.11e-04 | 29 | 148 | 3 | EFO_0010434 | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 5.16e-04 | 7 | 148 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | Akinetic Petit Mal | 5.16e-04 | 7 | 148 | 2 | C0001890 | |
| Disease | Epilepsy, Absence, Atypical | 5.16e-04 | 7 | 148 | 2 | C0751124 | |
| Disease | Absence Seizure Disorder | 5.16e-04 | 7 | 148 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 5.16e-04 | 7 | 148 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 5.16e-04 | 7 | 148 | 2 | C4281785 | |
| Disease | Epilepsy, Minor | 5.16e-04 | 7 | 148 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 5.16e-04 | 7 | 148 | 2 | C0014553 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 5.16e-04 | 7 | 148 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | triacylglycerol 54:5 measurement | 5.51e-04 | 32 | 148 | 3 | EFO_0010423 | |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 6.86e-04 | 8 | 148 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | level of Triacylglycerol (53:4) in blood serum | 6.86e-04 | 8 | 148 | 2 | OBA_2045166 | |
| Disease | SAPHO syndrome | 7.19e-04 | 35 | 148 | 3 | EFO_1001164 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 7.82e-04 | 36 | 148 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Seizures | 8.37e-04 | 218 | 148 | 6 | C0036572 | |
| Disease | Allodynia | 8.59e-04 | 84 | 148 | 4 | C0458247 | |
| Disease | Mechanical Allodynia | 8.59e-04 | 84 | 148 | 4 | C2936719 | |
| Disease | Hyperalgesia, Secondary | 8.59e-04 | 84 | 148 | 4 | C0751212 | |
| Disease | Hyperalgesia, Primary | 8.59e-04 | 84 | 148 | 4 | C0751211 | |
| Disease | Hyperalgesia, Thermal | 8.59e-04 | 84 | 148 | 4 | C0751214 | |
| Disease | Tactile Allodynia | 8.59e-04 | 84 | 148 | 4 | C0751213 | |
| Disease | Hyperalgesia | 8.59e-04 | 84 | 148 | 4 | C0020429 | |
| Disease | triglyceride measurement, blood pressure | 8.79e-04 | 9 | 148 | 2 | EFO_0004325, EFO_0004530 | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 8.79e-04 | 9 | 148 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | degree of unsaturation measurement | 9.90e-04 | 39 | 148 | 3 | EFO_0022261 | |
| Disease | ciliopathy (implicated_via_orthology) | 1.07e-03 | 40 | 148 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | Inherited neuropathies | 1.07e-03 | 40 | 148 | 3 | C0598589 | |
| Disease | cups of coffee per day measurement | 1.07e-03 | 40 | 148 | 3 | EFO_0006782 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.10e-03 | 10 | 148 | 2 | OBA_2045163 | |
| Disease | diacylglycerol 32.2 measurement | 1.10e-03 | 10 | 148 | 2 | EFO_0020055 | |
| Disease | volumetric bone mineral density | 1.23e-03 | 42 | 148 | 3 | EFO_0007620 | |
| Disease | triacylglycerol 56:6 measurement | 1.32e-03 | 43 | 148 | 3 | EFO_0010433 | |
| Disease | diacylglycerol 34:3 measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0020059 | |
| Disease | sialic acid-binding Ig-like lectin 14 measurement | 1.60e-03 | 12 | 148 | 2 | EFO_0008284 | |
| Disease | Lenticulostriate Disorders | 1.60e-03 | 12 | 148 | 2 | C0750951 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.60e-03 | 12 | 148 | 2 | C3501847 | |
| Disease | Extrapyramidal Disorders | 1.60e-03 | 12 | 148 | 2 | C0015371 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.60e-03 | 12 | 148 | 2 | C3495587 | |
| Disease | nervous system disease (implicated_via_orthology) | 1.60e-03 | 12 | 148 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.60e-03 | 12 | 148 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.60e-03 | 12 | 148 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.60e-03 | 12 | 148 | 2 | C3711543 | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 1.60e-03 | 12 | 148 | 2 | OBA_2045171 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.60e-03 | 12 | 148 | 2 | C1848172 | |
| Disease | Basal Ganglia Diseases | 1.60e-03 | 12 | 148 | 2 | C0004782 | |
| Disease | JT interval | 1.62e-03 | 248 | 148 | 6 | EFO_0007885 | |
| Disease | Generalized seizures | 1.70e-03 | 101 | 148 | 4 | C0234533 | |
| Disease | Clonic Seizures | 1.70e-03 | 101 | 148 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 1.70e-03 | 101 | 148 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 1.70e-03 | 101 | 148 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 1.70e-03 | 101 | 148 | 4 | C0751056 | |
| Disease | Atonic Absence Seizures | 1.70e-03 | 101 | 148 | 4 | C0751123 | |
| Disease | Complex partial seizures | 1.70e-03 | 101 | 148 | 4 | C0149958 | |
| Disease | Single Seizure | 1.70e-03 | 101 | 148 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 1.70e-03 | 101 | 148 | 4 | C3495874 | |
| Disease | Visual seizure | 1.70e-03 | 101 | 148 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 1.70e-03 | 101 | 148 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 1.70e-03 | 101 | 148 | 4 | C0422855 | |
| Disease | Gustatory seizure | 1.70e-03 | 101 | 148 | 4 | C0422854 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GVIIGSIFEVIWAVI | 556 | O00555 | |
| LWNILDFIVVSGALV | 1311 | O00555 | |
| VGLWLVVFVLALVAA | 796 | P48751 | |
| INIWRDVGLFGVLNE | 81 | Q9NRG9 | |
| GLLWVGTDQGVIVLL | 1076 | Q9HCE6 | |
| LWNILDFVVVVGALV | 1221 | Q15878 | |
| LVVWIVIGFIDFGVV | 936 | P35670 | |
| TGLVVFLLIVFWGIL | 331 | Q8IUA7 | |
| VAQFHEWQAGIGLIL | 176 | P54840 | |
| AVGLLGNAFVVWLLA | 51 | O00155 | |
| WQVVFIAFLTGILAL | 66 | P20309 | |
| DVIGALLNVFVWIGY | 356 | P28223 | |
| WGRIVTIFAFEGILI | 86 | Q16548 | |
| LGDFVVGERVWVNGV | 76 | Q9UDT6 | |
| WVVSVVLAVPEAIGF | 226 | P24530 | |
| TVVWLGVLSLGFALV | 111 | Q9NUS5 | |
| AGAVAVFLILRIWVV | 11 | Q96F25 | |
| GTWLQVLETIGVLAV | 596 | A1A5B4 | |
| VVFLVGVLGNALVVW | 46 | P21730 | |
| GVLGNALVVWVTAFE | 51 | P21730 | |
| QAGWIEGAAILFSVI | 146 | P23634 | |
| FILGAVILGFGVWIL | 21 | P27701 | |
| ATLLVWIVIGFLNFE | 951 | Q04656 | |
| VGSNIIVFERLWEGL | 36 | P56750 | |
| VLVLSLWGAVVGAQN | 11 | Q15109 | |
| LGGLIVVWVGFFILL | 341 | Q8NHS3 | |
| LFLAEVVLVGWVKFV | 161 | Q9BRQ5 | |
| LENAGSVGLALIVWI | 66 | Q9UHI5 | |
| SVGLALIVWIVTGFI | 71 | Q9UHI5 | |
| LFIIILAAWEAGRGQ | 16 | Q9UN72 | |
| WAEALGVLLGAVVQI | 146 | Q86V59 | |
| NGWNLLDFIIVVVGL | 161 | O60840 | |
| AWVGGFLHATIQILF | 146 | Q96R67 | |
| DAWVAEIGLAFNILG | 331 | Q96NT5 | |
| LGLVASVLVGVWVKA | 156 | Q9BZJ8 | |
| LLFGIIFWVIAVAHG | 96 | Q14500 | |
| IWASGVVLLETVLFG | 411 | Q6PRD1 | |
| VLGFLAVWTVGALER | 501 | Q6PRD1 | |
| TFVLGVLGNGLVIWV | 36 | P25090 | |
| TWLEAVIFLIGIIVA | 316 | P05023 | |
| LFGWLLIGVVAILVF | 186 | Q9HA72 | |
| VTTLLGVAVGGFVLW | 11 | Q9NVH0 | |
| VGWITGAAVAVLLLL | 11 | Q6UXD1 | |
| GLLWQVIKIGLFADI | 226 | P13796 | |
| LVLWLGGFIHSIVQV | 146 | Q8IXE1 | |
| TLVGNLGIIVLIFWD | 36 | Q8NH48 | |
| NLWVYLEAVFVGGDI | 1496 | Q96JB1 | |
| VWLVINLGSGAFEAL | 346 | Q9P2S2 | |
| GAIVVAASVWLLIGN | 411 | O60669 | |
| RILVAGGIAGIFNWA | 211 | O43772 | |
| AWFLLVLAVVAGDTV | 11 | Q86TH1 | |
| VFIGIAAAVLWTAQG | 106 | O43934 | |
| FIAVVQAIVRTAGGW | 196 | B5MD39 | |
| LDAIWGIVVEAVAGA | 51 | Q9NZH0 | |
| VVALIGNVLVCVAVW | 66 | O43614 | |
| LLVIFAIEIAAAIWG | 96 | P21926 | |
| DVIWVILSVEVGGLL | 171 | Q9H6K1 | |
| DGVIVVISVWEIVGQ | 811 | O43497 | |
| WVFIGGLLQALITAL | 346 | P43003 | |
| FIFGIIGVQLWAGLL | 221 | Q9P0X4 | |
| IVIISIWEIVGQADG | 711 | Q9P0X4 | |
| WLVFIVGALGNSLVI | 56 | P51686 | |
| AWVGFVVQAVQVGIV | 306 | Q6NUI2 | |
| VLWLGALGLTIQAVF | 51 | Q9NUB4 | |
| FKGLEGLQVAWLVVE | 206 | Q9NYL2 | |
| TWLEAVIFLIGIIVA | 306 | P13637 | |
| VNEGLSIFVILVWLG | 6 | P04839 | |
| LLAIVGYVAVGIIAW | 41 | Q8IWA5 | |
| WLFGVAAVVTDVGQI | 151 | Q8WYP5 | |
| AVVAVGLNTGRWLVL | 651 | Q32P44 | |
| LAVQWGAIGDVGILV | 2056 | P49327 | |
| DGIIVVISVWEIVGQ | 861 | O95180 | |
| VISVWEIVGQADGGL | 866 | O95180 | |
| ILFLRLTWIVGVAGV | 136 | Q9Y666 | |
| LTWIVGVAGVLESFL | 141 | Q9Y666 | |
| INIFGVVLFLRTGWL | 51 | A0AV02 | |
| LGNIWAVRGISVAVL | 151 | A0AV02 | |
| FGGLLVAIAVEHWNL | 91 | Q13183 | |
| IGVLIIALAINSWGI | 546 | Q13183 | |
| LGGLIVAVAVERWNL | 91 | Q86YT5 | |
| GWLLTVAVGNIIVLI | 621 | P46059 | |
| AGIQAVTALLFVWIA | 546 | Q8IY34 | |
| WDLLGELALVVFSVV | 341 | Q9BZV2 | |
| IAAVLFWGGGVLLFI | 401 | Q9H015 | |
| GWNLLDFVIVIVGLF | 196 | Q01668 | |
| GVIIVSLIFDGNWNG | 91 | Q96LT7 | |
| IWAVGITAIELGELQ | 201 | Q9Y4K4 | |
| VAAWVGGFVHSIVQL | 146 | Q15615 | |
| GNLGLVVLVIEDSWL | 71 | Q8NGG3 | |
| QFGIVVYVVGWALLA | 46 | O15547 | |
| GVILFLRLTWVVGIA | 136 | Q9H2X9 | |
| VLIAVVGGILYQSAW | 206 | Q12908 | |
| SAALWLAIGIIQVVF | 736 | Q5HYA8 | |
| LLLVVSWVGGFLQSV | 141 | Q8NGN8 | |
| VAAWLGGFVHSIVQI | 146 | Q8NGI6 | |
| LRIWGFILGQIVLVV | 121 | Q9H720 | |
| FHLLVAVDGINALWG | 256 | P51398 | |
| IAANGFIVLVLGREW | 21 | P59536 | |
| LLFGVIFWVIAVAHG | 96 | B7U540 | |
| ILAQVGFSVGLGNVW | 71 | Q9H2J7 | |
| IINGLIGTVLSEFLW | 401 | Q8WV83 | |
| WNIFDFVVVILSIVG | 1416 | P35499 | |
| LGWQVILEQILFILG | 96 | Q8WUG5 | |
| GVIDIIGNITFGWLT | 326 | Q6ZSM3 | |
| VIGVAIISLIIWGLN | 246 | O15400 | |
| TFVLGVLGNGLVIWV | 36 | P21462 | |
| VLSVAGEIIGLGNVW | 46 | P48065 | |
| WAVVVLFVIGLFAAG | 1081 | Q96PQ0 | |
| WNIFDFVVVILSIVG | 1591 | Q14524 | |
| VGWNIFDFVVVIISI | 1576 | Q15858 | |
| WLVGLAAVVGFLFIV | 31 | O75264 | |
| GLKAVIWTDVFQVGI | 181 | Q8N695 | |
| VGFLAAVAAIILGWI | 251 | Q96JW4 | |
| RIGDIGFILALAWFI | 176 | P03915 | |
| NLGLVWLAVVALGAV | 661 | Q9C0C4 | |
| WAFSVSEINGIILVG | 126 | Q8NHU3 | |
| IISLVGLTGNAVVLW | 36 | Q96LA9 | |
| QWVGTVLVFLGLGLD | 296 | P78383 | |
| DGDQTLILGLIWVII | 141 | Q9NRC6 | |
| VWGVVLNQAFGGLLV | 271 | P78381 | |
| LQIAWVGGFIAISII | 321 | Q13433 | |
| VADVVLWSVLQQIGG | 276 | Q13155 | |
| IGNSIVVAQVVWEGL | 36 | P56747 | |
| IGNSIVVAQVVWEGL | 36 | O95484 | |
| AGKAVIVIQDIFGWQ | 41 | Q96DG6 | |
| IVIIFIWLLASLIGG | 156 | P46091 | |
| EFLIGLIGNGSLVVW | 16 | Q9NYW4 | |
| NGLLVVGAISAIFWA | 306 | Q8IU68 | |
| IVFWVLGALFLAIGL | 26 | Q96FV3 | |
| NWFIIAGVLLDIQEV | 61 | Q6ZMD2 | |
| ALVVAVALGVLVWAA | 71 | O60831 | |
| VLAVGLLVLWVAGGA | 106 | O60831 | |
| GAVLSVGADVQFRIW | 136 | Q9UBI4 | |
| ELTIGIWGNGFIVLV | 16 | Q9NYW1 | |
| EWVFVGLVLLGVFLF | 186 | Q71H61 | |
| ILSVGLWVLSGIVAF | 216 | Q92504 | |
| VTLLWIIELNVNGGI | 66 | O95772 | |
| AAGSINGLIIVWNVE | 246 | O75717 | |
| IVILVGTGVIAVFFW | 776 | P35916 | |
| GTGVIAVFFWVLLLL | 781 | P35916 | |
| VAALGLQWGTIVQGI | 86 | Q02094 | |
| NKWAALFGAIISVVI | 566 | P55017 | |
| LGTILIFAVVGTLWN | 186 | P19634 | |
| LVVAVAGVVLAKGSW | 206 | Q3KNW5 | |
| QVLLGILGFQAAWVS | 6 | A0A0B4J273 | |
| FIFWITGVILLAVGI | 26 | O43657 | |
| GAAVLAVGIWTLVEK | 31 | A1L157 | |
| IFGTLVQRWLEVQVA | 851 | Q92543 | |
| VNLGLSGVNILWIFG | 546 | Q96SK2 | |
| GQVQTFLLWGAGALV | 126 | Q9BVC6 | |
| FLVIWLVGFIADLNI | 311 | Q8IUH5 | |
| LIVWAIGGLFSVVGA | 81 | Q92536 | |
| LVLEAVAGALVVALW | 161 | Q9H1Z9 | |
| VWLQENLLAVGIFGL | 196 | O14817 | |
| IDLRGGLLQVFWGQE | 2236 | Q7Z7G8 | |
| AGWVAVGLEAVVIGE | 21 | Q8N0Z9 | |
| NRLTWIVVVLQALGG | 241 | Q9Y2D2 | |
| LGVGAGVFILALLWV | 6 | A2RU14 | |
| VNGKIIVWDVAAGVA | 91 | Q9BZH6 | |
| IAIGGFEWNALVLVV | 96 | P13866 | |
| ESFLGGVLLILWLQV | 21 | A0A075B6T7 | |
| GVAGQWRFVDVLGLE | 21 | P09936 | |
| VNVFLGIGVAWSIAA | 876 | P32418 | |
| NVFLGIGLAWSVAAI | 831 | P57103 |